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resumo 
 
 
A terapia fotodinâmica antimicrobiana representa uma alternativa promissora 
para inactivar eficientemente microrganismos patogénicos como bactérias, 
vírus, fungos e protozoários. Esta terapia baseia-se na utilização de um 
fotossensibilizador, que quando é activado por luz, gera espécies citotóxicas 
que destroem as células-alvo. A inactivação fotodinâmica das células 
microbianas pode ocorrer através de dois mecanismos oxidativos: a via do tipo 
I que envolve reacções de transferência de electrões/átomos de hidrogénio do 
fotossensibilizador com produção de radicais iónicos e a via do tipo II que 
envolve a transferência de energia do fotossensibilizador para oxigénio 
molecular com a subsequente formação de oxigénio singuleto. Tendo em 
conta os mecanismos de inactivação envolvidos no processo fotodinâmico das 
células microbianas alvo, o aparecimento de estratégias de resistência à 
terapia fotodinâmica e a recuperação da viabilidade microbiana parecem ser 
improváveis. O objectivo deste trabalho foi investigar o(s) mecanismo(s) 
envolvido(s) na inactivação fotodinâmica da bactéria recombinante 
bioluminescente Escherichia coli, utilizando três porfirinas catiónicas meso-
substituídas como fotossensibilizadores. Foi também avaliada a possibilidade 
de recuperação da viabilidade bacteriana após fotoinactivação e a 
probabilidade de desenvolvimento de resistência bacteriana à terapia 
fotodinâmica antimicrobiana, utilizando duas bactérias Gram-negativas: Vibrio 
fischeri e E. coli bioluminescente. Para investigar o(s) mecanismo(s) de 
fotoinactivação dos três fotossensibilizadores, foram usados vários inibidores 
de oxigénio singuleto e de radicais livres. Suspensões de E. coli a 107 UFC 
mL-1 foram distribuídas em copos esterilizados e adicionadas de porfirina à 
concentração final de 5.0 µM para os derivados porfirínicos Tetra-Py+-Me e Tri-
SPy+-Me-PF e 0.5 µM para a porfirina Tri-Py+-Me-PF. Para testar o mecanismo 
do tipo I foram usados como inibidores de radicais livres L-cisteína e D-manitol 
(100 mM). Para testar o mecanismo do tipo II foi usada a azida sódica (100 
mM) como inibidor do oxigénio singuleto. As amostras foram expostas durante 
270 minutos à luz branca (4 mW cm-2). A recuperação bacteriana foi testada 
através de um ensaio de fotoinactivação de 270 minutos a luz branca (4 mW 
cm-2) expondo as as suspensões bacterianas de V. fischeri e E. coli a 5.0 µM 
do derivado porfirínico Tri-Py+-Me-PF e mantendo as amostras no escuro 
durante uma semana de incubação após o tratamento. Para avaliar o possível 
desenvolvimento de resistência pelas células bacterianas à terapia 
fotodinâmica, suspensões bacterianas de V. fischeri e de E. coli foram 
expostas a luz branca (4 mW cm-2) durante 25 minutos com 5.0 μM de porfirina 
Tri-Py+-Me-PF. Colónias isoladas de células sobreviventes após o primeiro 
tratamento foram novamente expostas à luz visível usando o mesmo protocolo 
de irradiação. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
  
 
 
Este procedimento foi repetido dez vezes para cada estirpe. Os resultados 
obtidos neste trabalho indicam que as reacções mediadas pelo oxigénio 
singuleto (mecanismo do tipo II) têm um papel predominante sobre o 
mecanismo do tipo I no processo de fotoinactivção da bactéria 
bioluminescente E. coli pelos derivados Tri-Py+-Me-PF, Tetra-Py+-Me e Tri-
SPy+-Me-PF. As bactérias inactivadas através da terapia fotodinâmica não 
recuperaram a sua actividade após uma semana de incubação no escuro. As 
estirpes V. fischeri e E. coli não desenvolveram resistência a esta terapia ao 
fim de dez gerações. Apesar do uso de inibidores representar um método 
simples e eficiente para determinar qual(is) a(s) via(s) implicada(s) no 
processo de inactivação fotodinâmica, a escolha dos inibidores deve ter em 
conta a estrutura química do fotossensibilizador. A ausência de 
desenvolvimento de resistência bacteriana e a não recuperação da viabilidade 
bacteriana após uma semana de incubação indica que a terapia fotodinâmica 
antimicrobiana representa um método adequado para inactivar bactérias de 
forma eficaz usando Tri-Py+-Me-PF. 
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abstract 
 
The antimicrobial photodynamic therapy seems to be a very promising 
possibility for the efficient inactivation of pathogenic microorganisms and it has 
been demonstrated in bacteria, virus, fungi and protozoa. The concept of this 
therapy is that a photosensitizer localized in the target cells, when activated by 
light, generates cytotoxic species that destroy those cells. Two oxidative 
mechanisms of photoinactivation are considered to be implicated in the 
inactivation of the target cells: the type I pathway that involves 
electron/hydrogen atom-transfer reactions to produce radical ions and the type 
II pathway that involves energy transfer to produce singlet oxygen from 
molecular oxygen. Having into consideration the type of damages that occur in 
the microorganisms after the photoinactivation process, the emergence of 
strategies of resistance to photodynamic therapy and microbial recovery seem 
to be unlikely. The aim of this work was to investigate the mechanism(s) 
involved in the photodynamic inactivation of a recombinant bioluminescent 
Escherichia coli, using three meso-substituted cationic porphyrin derivatives as 
photosensitizers. It was also evaluated in this study the possible recovery of 
bacterial viability after photodynamic inactivation and the probable 
development of bacterial resistance to antimicrobial photodynamic therapy 
using two Gram-negative bacteria: Vibrio fischeri and the bioluminescent E. 
coli. To investigate the mechanism(s) of photoinactivation of the three 
photosensitizers in study, various scavengers of singlet oxygen and of free 
radicals were used. Suspensions of E. coli at 107 CFU mL-1 were distributed in 
sterilized beakers and the porphyrins were added to a final concentration of 5.0 
µM for the porphyrinic derivatives Tetra-Py+-Me and Tri-SPy+-Me-PF 
porphyrins and 0.5 µM for Tri-Py+-Me-PF porphyrin. To test type I mechanism 
L-cysteine (100 mM) and D-mannitol (100 mM) were used as free radical 
scavengers. To test type II mechanism, sodium azide (100 mM) was used as 
singlet oxygen quencher. The mixtures were exposed for 270 minutes to white 
light (4 mW cm-2). The bacterial recovery was tested with a photoinactivation 
assay of 270 minutes with white light (4 mW cm-2) exposing bacterial 
suspensions of V. fischeri and E. coli to 5.0 µM of the porphyrinic derivative Tri-
Py+-Me-PF and maintained the samples in the dark during one week of 
incubation after treatment. In order to assess the possible development of 
resistance of bacterial cells after photoinactivation, bacterial suspensions of V. 
fischeri and E. coli were exposed to white light (4 mW cm-2) for 25 minutes with 
5.0 μM of Tri-Py+-Me-PF. After the first irradiation period, surviving colonies 
were reexposed to visible light using the same irradiation protocol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 This procedure was repeated ten times for each strain. The results obtained in 
this work suggest that singlet oxygen-mediated reactions (type II mechanism) 
play the most important role on the photoinactivation process of the 
bioluminescent E. coli by Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF 
derivatives. The results also show that inactivated bacteria do not recover their 
viability after photoinactivation and that no resistance to photodynamic therapy 
appears after ten generations for V. fischeri and E. coli. Although the use of 
scavengers represents a simple and an efficient approach to determine which 
pathway(s) is(are) implicated in the photodynamic inactivation process, the 
choice of the scavenger must take into account the chemical structure of the 
photosensitizer. The antimicrobial photodynamic therapy represents an 
adequate method to inactivate bacteria, since bacterial cells do not recover 
their viability after one week of incubation nor develop resistance to the 
photoinactivation process using Tri-Py+-Me-PF. 
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INTRODUCTION 
 
CHAPTER 1 - INTRODUCTION 
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PHOTOTHERAPY AND PHOTODYNAMIC EFFECT 
The term “phototherapy” describes the use of light in the treatment of diseases 
(Ackroyd et al., 2001; Moan and Peng, 2003) and its use goes back to the ancient 
civilizations (Bonnett, 2000). It was used in ancient Egypt, India and China to treat skin 
diseases such as psoriasis, vitiligo and cancer as well as rickets and even psychosis (Spikes, 
1985; Epstein, 1990). The famous Greek physician Herodotus, regarded as the father of 
heliotherapy, emphasized the importance of sun exposure for the restoration of health. 
However, it was not until recently that the therapeutics effects of sunlight were widely 
used in medicine (Ackroyd et al., 2001; Moan and Peng, 2003). In the past two centuries, 
in France, sunlight was used in the treatment of various conditions, such as tuberculosis, 
rickets, scurvy, rheumatism, paralysis, edema and muscle weakness (Ackroyd et al., 2001). 
Phototherapy was further developed by the Danish physician Niels Finsen who, at the 
turn of the last century, described the successful treatment of smallpox using red light 
which prevented suppuration of the pustules (Finsen, 1901). Then ultraviolet light was 
used by Finsen (1901) to treat cutaneous tuberculosis and the use of carbon arc 
phototherapy was developed for the treatment of this condition. These studies allowed 
Finsen to be awarded a Nobel Prize in 1903 and to be acknowledged as the founder of 
modern phototherapy (Ackroyd et al., 2001; Moan and Peng, 2003). In 1950, Richard 
Cremer introduced the phototherapy as a treatment of jaundice in newborn babies 
(Cremer et al., 1958). 
The term “photodynamic effect” was introduced in 1907 by Von Tappeiner and 
Jodlbauer and is used to refer to the damage and destruction of living cells or tissues in 
the presence of a photosensitizer (PS), light and oxygen (Von Tappeiner and Jodlbauer, 
1907). The photodynamic effect was initially observed in 1900 by Oscar Raab, a medical 
student working with the Professor Herman Von Tappeiner (Ackroyd et al., 2001; Bonnett 
et al., 2006). During the course of his study on the effects of the acridine red dye on 
Paramecium caudatum he discovered that the combination of acridine red and light had a 
lethal effect on the paramecia and demonstrate that this effect was greater than of either 
acridine alone, light alone or acridine exposed to light and then added to the paramecia 
(Raab, 1900; Ackroyd et al., 2001). He also discovered the optical property of acridine red 
 4 
 
fluorescence and concluded that it was not the light but rather some product of the 
acridine that induced in vitro toxicity. He suggested that this effect was caused by the 
transfer of energy from light to the chemical (Ackroyd et al., 2001). The first report of 
parenteral administration of a PS in humans was in 1900 by the French neurologist Prime 
who used eosin orally in the treatment of epilepsy and discovered that this induced 
dermatitis in sun-exposed areas of skin (Prime, 1900). With this discovery, Von Tappeiner 
and the dermatologist Jesionek used a combination of topical eosin and white light to 
treat skin tumours leading to the first medical application of an interaction between a 
fluorescent compound and light (Von Tappeiner and Jesionek, 1903). 
 
PHOTODYNAMIC THERAPY 
Photodynamic therapy (PDT) is a therapy for cancer and other diseases (Hamblin 
and Hasan, 2004) and is based on the photodynamic principle. The PDT comprises the use 
of light (normally visible light and laser light directed via optical fiber) (Shackley et al., 
1999), molecular oxygen and a non-toxic photosensitizing agent (given systemically, 
topically or directly into the organ) able to absorb and transfer the energy of the light to 
molecular oxygen (Dougherty et al., 1998; Shackley et al., 1999) leading to the formation 
of highly cytotoxic reactive oxygen species (ROS) (singlet oxygen [1O2], hydrogen peroxide 
[H2O2], superoxide [O2-·] and hydroxyl radicals [HO-·]). Such species are able to irreversibly 
alter the cells' vital constituents resulting in oxidative lethal damage of the target cell 
(Figure 1) (Wainwright, 1998; De Rosa and Crutchley, 2002). PDT was developed in the 
1960's by Lipson and Schwartz at the Mayo Clinic (USA) who observed that injection of 
crude preparations of hematoporphyrin, a non-pure porphyrin resulting by removal of 
iron from dried blood by treatment with sulfuric acid (Scherer, 1841), led to fluorescence 
of neoplastic lesions visualized during surgery. To gain an optimal tumour localization 
preparation, Schwartz treated hematoporphyrin with acetic acid and sulphuric acid and 
after neutralization, obtain a porphyrin mixture that he termed “hematoporphyrin 
derivate” (HpD), which was used by Lipson et al. (Dougherty and Henderson, 1992) for 
tumour detection. HpD contains several porphyrins, monomers as well as dimers and 
oligomers (Dougherty et al., 1998). HpD has been partially purified with the less-active 
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porphyrins' monomers removed, to constitute Photofrin® (Dougherty, 1996), the most 
widely used PS in clinical PDT. Because of the long-lasting skin phototoxicity of 
Photofrin®, several PS have been introduced in clinical trials (Gomer, 1991; Pass, 1993). 
Photofrin® absorbs light only up to about 640 nm. Light at longer wavelengths penetrates 
farther into tissue and most of the new sensitizers have stronger absorbance at 650–850 
nm (Dougherty et al., 1998). 
 
 
Figure 1 – Principle of photodynamic therapy (Maisch, 2009b). 
 
PDT has the advantage over other therapies of dual selectivity: not only is the PS 
targeted to the tumour or other lesion, but the light can also be accurately delivered to 
the affected tissue (Hamblin and Hasan, 2004). The main attraction of PDT is the lack of 
scarring since connective tissues (including collagen and elastin) tend to be unaffected. 
The mechanical and functional integrity of the organ is thus left intact (Shackley et al., 
1999). 
Although originally developed as a cancer treatment, the most successful PDT 
application to date has been in ophthalmology as a treatment for age-related macular 
degeneration and has received, in 2000, the USA's Food and Drug Administration 
approval (Bressler and Bressler, 2000; Hamblin and Hasan, 2004; Wickens and Blinder, 
2006). Other non-oncological applications of PDT at a less developed stage include 
treatments of psoriasis (Boehncke et al., 2000), Barretts's esophagus (Barr, 2000), arthritis 
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(Trauner and Hasan, 1996), artheroscerlosis (Rockson et al., 2000) and restenosis in both 
veins and arteries (Jenkins et al., 1999). Besides, resistance to treatment does not seem 
to develop with repeated use (Lauro et al., 2002). However, photodynamic therapy in its 
current form has several limitations (Shackley et al., 1999). It is an ablative treatment that 
yields no biopsy material, so a definitive diagnosis must be made before treatment. It is 
more complex than other treatment modalities since optimal delivery of light (usually by 
laser) and drug requires collaboration between scientists and clinicians (Shackley et al., 
1999). 
 
ANTIMICROBIAL PHOTODYNAMIC THERAPY 
The fact that many human and animal diseases can be caused by microorganisms 
(MO) has been recognised for many centuries. In the last 150 years, there has been a 
huge increase in knowledge of the natural history of MO themselves and how they are 
implicated in the transmission of diseases (Jori and Brown, 2004). The development and 
widespread use of antibiotics to treat bacterial infections represents one of the most 
revolutionary advances ever made in scientific medicine. It might have been expected 
that microbiological-based diseases at the beginning of the twenty first century would 
have been reduced to a level that no longer had a serious impact on human health (Jori 
and Brown, 2004). However, the rapid emergence of antibiotic resistance among 
pathogenic MO may be bringing to an end a period extending over the past 50 years, 
termed the “antibiotic era” (Yoshikawa, 2002; Hamblin and Hasan, 2004). Bacteria 
replicate very quickly and a mutation that helps a microbe to survive in the presence of 
an antibiotic drug will promptly become predominant throughout the microbial 
population. The problem is further exacerbated by factors of social nature such as the 
inappropriate or excessive prescription of antibiotics, the failure of some patients to 
complete their treatment regimen, the more and more frequent transmission of MO due 
to the global travelling, the expansion of poverty among populations in the third world 
countries, as well as by the truly large variety of mechanisms adopted by microbial cells to 
increase their resistance to external insults (Michel and Gutmann, 1997; Hamblin and 
Hasan, 2004; Jori et al., 2006). These include a thickening of their outer wall, encoding of 
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new proteins which prevent the penetration of drugs, onset of mutants deficient in those 
porin channels allowing the influx of externally added chemicals, among others (Harder et 
al., 1981; Roland et al., 1994; Boyle-Vavra et al., 2001). Due to resistance to all ß-lactam 
antibiotics, vancomycin, a glycopeptid antibiotic, remained as last line of defense against 
Gram-positive [Gram (+)] bacteria and methicillin-resistant Staphylococcus aureus 
(MRSA), however vancomycin-resistant enterococci are resistant species that are causing 
much concern at present (Cunha, 1998). The emergence of antibiotic resistance among 
pathogenic bacteria has led to a major effort to find alternative antibacterial methods, 
more efficient and faster, non-invasive and non-toxic, which would not lead to microbial 
resistance (Sommer et al., 2000; Hamblin and Hasan, 2004). One of these non-invasive 
methods, based on the use of light sources, is the antimicrobial photodynamic therapy 
(aPDT) (Calin and Parasca, 2009; Maisch, 2009b). 
The aPDT seems to be a very promising possibility for the efficient inactivation of 
pathogenic MO (Wainwright, 1998). The aPDT approach was demonstrated in bacteria, 
virus and protozoa (Wainwright, 1998; Bonnett, 2000; Wainwright, 2004; Alves et al., 
2008; Costa et al., 2008) and is based on the PDT concept: a PS localized in the target 
cells, when activated by light (visible light as artificial or sunlight), generates cytotoxic 
species that destroy those cells. 
The antimicrobial properties of aPDT have been known for about a century and 
several studies have shown that antibiotic resistant bacteria are as susceptible to 
photodynamic inactivation (PDI) as their naive counterparts. The nature of the PDI-
induced damage that involves oxidative modification of vital cellular constituents 
suggests that MO will not easily be able to develop resistance mechanisms (Lauro et al., 
2002; Demidova and Hamblin, 2005). 
At the moment, the main application of aPDT is in the clinical area for the 
sterilization of blood and blood products, preventing of viral contamination. Remarkably, 
the human immunodeficiency virus has been inactivated in vitro by aPDT (Wagner et al., 
1994; Grandadam et al., 1995; Hirayama et al., 1997; Wainwright, 2000; Ben-Hur et al., 
2002; Floyd et al., 2004). Further applications of aPDT would be skin surface disinfection, 
decolonization of nasal MRSA and treatment of superficial skin wounds (Hamblin and 
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Hasan, 2004; Maisch et al., 2004). More recently, aPDT was mentioned as a promising 
alternative to antibiotics to treat oral cavity infections (such as periodontitis, 
endodontitis, treatment of superificial oropharyngeal Candida infections), Tinea pedis 
infection, and acne vulgaris (Jori et al., 2006; Maisch, 2007; Maisch, 2009a). Currently, the 
aPDT has been studied having in view not only its application to the clinical field, but also 
to the environmental area (Alouini and Jemli, 2001; Jemli et al., 2002; Bonnett et al., 
2006; Jiménez-Hernández et al., 2006; Carvalho et al., 2007; Drábková et al., 2007; Alves 
et al., 2008; Costa et al., 2008; Carvalho et al., 2009; Oliveira et al., 2009). 
This approach has been considered as a possibility to drinking water disinfection 
process and in wastewater treatment plants as tertiary treatment option in order to 
overcome the lack of water resources, mainly in densely populated areas, where 
wastewater may be treated and disinfected to further reuse (Jemli et al., 2002; Rojas-
Valencia et al., 2004). Effectiveness of aPDT was observed on the destruction of faecal 
bacteria (Cerveny et al., 2002; Jemli et al., 2002; Bonnett et al., 2006; Jiménez-Hernández 
et al., 2006; Carvalho et al., 2007; Alves et al., 2008; Alves et al., 2009) and bacterial 
endospores (Oliveira et al., 2009), helminths eggs (Alouini and Jemli, 2001) and viruses 
(Casteel et al., 2004; Costa et al., 2008) in environmental waters. The applicability of the 
photodynamic principle as a new environmentally-friendly technology to water treatment 
may become viable if the PS is immobilized on a solid matrix. This solution allows the 
photoinactivation (PI) process and the subsequent retention of the PS, after 
photodynamic action, to avoid the release of the PS to the water output (Bonnett et al., 
2006; Jiménez-Hernández et al., 2006). As a consequence, some study groups have 
developed PS immobilized on solid supports and have tested the PI process against faecal 
bacteria (Bonnett et al., 1997; Artarsky et al., 2006; Bonnett et al., 2006; Jiménez-
Hernández et al., 2006; Almeida et al., 2009b; Carvalho et al., 2009). Preliminary results 
obtained with a meso-substituted tricationic porphyrin derivative immobilized in 
magnetic nanoparticles showed that inorganic-organic hybrids present antimicrobial 
activity and the fact of the inhert particles having a magnetic core allows the recovery and 
recycling of the photosensitizing agent (Almeida et al., 2009b; Carvalho et al., 2009). One 
of the tested inorganic-organic hybrids was able to inactivate Gram (+), Gram-negative 
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[Gram (-)] bacteria and T4-like bacteriophages to the limits of detection (up to 7 logs of 
PI) as the PS did in the unbound form (Costa et al., 2008; Almeida et al., 2009b). Besides, 
Jiménez-Hernandez et al. (2006) used as PS Ru(II) polypyridyl complexes grafted to 
polymer in a homemade microreactor, with a solar simulator source for laboratory-scale 
water disinfection assays, using a water sample containing Escherichia coli and 
Enterococcus faecalis (2 x 103 CFU mL-1) and obtained a significant photodisinfection with 
visible light for both microorganisms (Jiménez-Hernández et al., 2006). 
Only just a few studies have been made using aPDT for the treatment of fish farms 
plants. Preliminary results obtained suggest that the photodynamic technique, using 
porphyrin derivatives as PS, has also a great potential for the disinfection of fish farm 
waters (Magaraggia et al., 2006; Jori and Coppellotti, 2007; Arrojado, 2009). These studies 
showed that cell cultures of Gram (+) bacteria (e.g., MRSA), Gram (-) bacteria (e.g., E. 
coli), fungi (e.g., Candida albicans) and fungi-like pathogens (e.g., Saprolegnia spp.), and 
parasitic protozoa (e.g., Acanthamoeba palestinensis) showed a 5-6 logs decrease in the 
microbial population after 10 minutes of irradiation with low light intensities (50 mW cm-
2) in the presence of micromolar doses of PS (Jori and Coppellotti, 2007). Magaraggia et 
al. (2006) have also shown that micromolar concentration of a porphyrinic PS promoted 
the cure of saprolegniosis in trout-farming pools containing naturally or artificially 
Saprolegnia infected fish (inactivation of 6-7 logs at 100 mW cm-2 during 20 minutes) 
without perilesional damage of the fish (Magaraggia et al., 2006). Furthermore, Arrojado 
(2009) isolated nine bacterial species (Vibrio anguillarum, Vibrio parahaemolyticus, 
Photobacterium damselae subsp. damselae, Photobacterium damselae subsp. piscicida, 
Aeromonas salmonicida, E. coli, S. aureus, E. faecalis and Pseudomonas sp.) from fish farm 
water samples and verified that these bacteria were inactivated in vitro with a cationic 
porphyrin (up to 7 logs), at micromolar PS doses, after 90 to 270 minutes of irradiation 
with a very low light intensity of 4 mW cm-2. It was also determined the impact of aPDT in 
the total bacterial community of the fish farm water samples. Arrojado (2009) observed 
that microbial diversity of these waters was also affected by the photodynamic treatment 
and concluded that it is necessary to treat fish farm waters without the discharge of the 
water to the environment. These results showed that aPDT can be used to 
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photoinactivate fish bacterial pathogens in fish farm waters even during dark days of 
winter time and that more investigation is needed about the impact of aPDT in the 
environment (Arrojado, 2009). 
Irradiation of fish farm waters and wastewaters by solar light, which penetrates 
deeply into the water column, thereby allowing the uniform illumination of large volumes 
(Baker and Smith, 1982), makes this technology inexpensive since it is based on the use of 
free light sources. Moreover, aPDT approach is intrinsically low cost compared to the 
chemical compounds normally used in aquaculture systems and is conceived to be 
environmentally-friendly and to exhibit a high level of safety for various ecosystems, as 
well for humans, animals and plants (Almeida et al., 2009a). 
 
PHOTOSENSITIZERS 
A photosensitizer is usually an aromatic molecule that can be a natural or a 
synthetic compound which undergoes excitation after interaction with an appropriate 
radiation emitted from a light source (Table 1). This gives rise to activated species which 
are very reactive towards the chemical environment thus producing molecular damages 
on important biological targets (Wainwright, 1998). 
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Table 1 – Photosensitizer absorption maxima (adapted from Wainwright, 1998). 
Photosensitizer type 
Wavelength(max) range 
in buffer (nm) 
Psoralen 
Acridine 
Phenazine 
Cyanine 
Perylenequinonoid 
Porphyrin 
Phenothiazinium 
Phthalocyanine 
300-380 
400-500 
500-550 
500-600 
600-650 
400-450 
620-660 
660-700 
 
A photosensitizing agent with potentially optimal properties should be endowed 
with specific features, in addition to the expected photophysical characteristics such as a 
high quantum yield for the generation of both the long-lived triplet state and the 
cytotoxic singlet oxygen species, a good absorption capacity at the wavelength of the 
spectral region where the light source is emitted and a good efficiency to generate ROS 
(Wainwright, 2000; De Rosa and Crutchley, 2002; Jori and Brown, 2004). Such features 
include (Jori et al., 2006): 
• broad spectrum of action, since one PS can act on bacteria, fungi, yeasts 
and parasitic protozoa; 
• efficacy independent of the antibiotic resistance pattern of the given 
microbial strain; 
• possibility to develop PDT protocols which lead to an extensive reduction in 
pathogen population with very limited damage to the host tissue; 
• lack of selection of photoresistant strains after multiple treatments; 
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• small probability to promote the onset of mutagenicity; 
• availability of formulations allowing a ready and specific delivery of the PS 
to the infected area; 
• use of low cost light sources for activation of the photosensitizing agent. 
 
A large number of different compounds with photodynamic activity are now 
available. First of all the synthetic non-porphyrin compounds have demonstrated 
photosensitizing ability, like the phenothiazine dyes: methylene blue and toluidine blue. 
Next, macrocyclic molecules have shown phototoxicity, like phthalocyanines and the 
metal containing porphyrins as well as the metal-free porphyrins. Another group of dyes 
belongs to the naturally occurring PS. Psoralens (furanocoumarins) and 
perylenequinonoids are two examples of natural products which originally act in plants as 
chemical defence substances against microbial or eukaryotic organisms (Maisch et al., 
2004). 
It would be desirable to have an effective PS for microbial inactivation without the 
need of additional chemicals. An important step forward in this direction was prompted 
by the discovery that PS that are positively charged at physiological pH values such as 
phenothiazines (Wilson et al., 1995), phthalocyanines (Minnock et al., 1996; Roncucci et 
al., 1999; Roncucci et al., 2004) and porphyrins (Merchat et al., 1996b) can directly 
promote the PI of both Gram (+) and Gram (-) bacteria. While phenothiazine derivatives 
are naturally cationic, owing to the involvement of one amino group in the π electron 
cloud resonance, porphyrins and phthalocyanines can be transformed into cationic 
entities trough the insertion of positively charged substituents in the peripheral positions 
of the tetrapyrrole macrocycle (meso positions) and, respectively, tetraazaisoindole 
macrocycle, which may largely affect the kinetics and extent of binding with microbial 
cells (Figure 2) (Jori et al., 2006; Magaraggia et al., 2006). 
Porphyrins as PS comprise of four pyrrole subunits linked together by four 
methane bridges (Figure 2). This tetrapyrrole ring structure is named porphin and 
derivatives of porphins are named porphyrins. Tetrapyrroles are naturally occurring 
pigments, which are used in many biological processes and include the metallopigments 
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heme (the prosthetic group of proteins like hemoglobin, cytochromes, catalase, 
peroxidase and tryptophan pyrrolase), vitamin B12, chlorophyll, siroheme (in nitrite and 
sulphite reductases) and factor F430 (cofactor of methyl-CoM reductase). All these 
compounds are synthesized with uroporphyrinogen III as a common intermediate and 
modified to permit coordination of different metals at the ring centre (iron in heme and 
siroheme, magnesium in chlorophyll, cobalt in vitamin B12 and nickel in factor F430). 
These tetrapyrroles do not induce any photochemical or photobiophysical reactions in 
other compounds or are rapidly quenched in their normal surroundings (e.g., chlorophyll) 
(Kristian, 2009). The intense Soret band, found around 400 nm, is a characteristic of these 
systems (Smith, 1975). 
 
 
Figure 2 – Basic chemical structure of phenothiazine (I), porphyrin (II), and phthalocyanine (III) photosensitizers and 
typical peripheral substituents (R) giving the PS a cationic character and enhancing the antimicrobial photosensitizing 
efficiency (Jori et al., 2006). 
 
As mentioned before, the photodynamic treatment efficiency also depends on 
several factors such as the presence or absence of charge, charge distribution and the 
presence of peripheral substituents (Costa et al., 2008; Alves et al., 2009). The porphyrin 
skeleton is essentially hydrophobic, thus this feature may be an important factor affecting 
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the preferential accumulation in cellular hydrophobic loci since such molecules must be 
able to get into cells by crossing lipid membranes which brings insolubility in water and 
physiological fluids (Derycke and De Witte, 2004; Lang et al., 2004; Bautista-Sanchez et 
al., 2005). The nature and number of the substituents generally have a limited influence 
on the photophysical properties of the parent compound. However, they may appreciably 
affect the kinetics and extent binding with microbial cells (Jori, 2006). 
Some studies compared the efficiency of synthetic meso-substituted cationic 
porphyrins with different charge distribution (tetra-, tri-, di- or monocationic) (Merchat et 
al., 1996b; Merchat et al., 1996a; Lazzeri et al., 2004; Caminos et al., 2005; Spesia et al., 
2005; Costa et al., 2008; Alves et al., 2009). However, the results achieved are different. 
Obtained results demonstrated that tetracationic porphyrins are efficient PS against both 
Gram (+) and Gram (-) bacteria on visible light (Merchat et al., 1996b). Other works 
demonstrated that some di- and tricationic porphyrins are more efficient than 
tetracationic ones, both against a Gram (+) strain and two Gram (-) strains (Merchat et al., 
1996a) and that a dicationic porphyrin as well as two tricationic porphyrins having a 
trifluoromethyl group are powerful photosensitizing agents against E. coli (Lazzeri et al., 
2004). More recently, Alves et al. (2009) investigated the efficiency of seven cationic 
porphyrins differing in meso-substituent groups, in charge number and in charge 
distribution, on the photodynamic inactivation of a Gram (+) bacterium (E. faecalis) and of 
a Gram (-) bacterium (E. coli). The results obtained indicate that the most effective PS 
against both bacterial strains were the studied tricationic porphyrins followed by the 
tetracationic porphyrin. However, the dicationic and the monocationic porphyrin 
derivatives were the least effective ones (Alves et al., 2009). Costa et al. (2008) also 
tested the same cationic porphyrins on the PI of T4-like sewage bacteriophages and 
similar results were obtained from those obtained with E. faecalis and E. coli (Costa et al., 
2008). These data indicate that the number of positive charges, the charge distribution in 
the porphyrins' structure and the meso-substituent groups seem to have different effects 
on the PI of both bacteria and bacteriophages (Costa et al., 2008; Alves et al., 2009). 
The nature and distribution of some functional groups in the molecule make it 
hydrophobic, hydrophilic or amphiphilic. A chemical compound is amphiphilic if it 
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possesses both hydrophilic and hydrophobic characteristics. In the transport of cell 
membranes, the lipid bilayer of the membrane allows for passive transport system of 
hydrophobic molecules. This means that molecules that repel water may diffuse across 
the cellular membrane without the need for an active transport system. Therefore, the 
hydrophobic PS can more easily diffuse across the cell membrane and improve the 
efficiency of photodynamic effect. The hydrophobicity degree of porphyrins can be 
modulated by either the number of cationic moieties (up to four in meso-substituted 
porphyrins) or by the introduction of hydrocarbon chains of different length on the amino 
nitrogens (Jori et al., 2006). But, as mentioned, the PS must be in solution, so it needs to 
be hydrophilic. Then, the ideal PS must have both hydrophilic and hydrophobic 
proprieties making it amphiphilic. There are some factors which increase the amphiphilic 
character of the porphyrins: the asymmetric charge distribution at their peripheral 
positions of the porphyrin, cationic charges combined into different patterns with highly 
lipophilic groups (e.g., trifluoromethyl groups), the introduction of aromatic hydrocarbon 
side groups and the modulation of the number of positive charges on the PS (Boyle and 
Dolphin, 1996; Ando and Kumadaki, 1999; Grancho et al., 2002; Spesia et al., 2005; Banfi 
et al., 2006; Caminos and Durantini, 2006). The increase in the amphiphilic character of 
the PS seems to enhance its affinity for MO which helps a better accumulation in the 
cell/particles (Boyle and Dolphin, 1996; Lazzeri et al., 2004; Spesia et al., 2005) 
accompanied by an increase in the photocytotoxic activity (Caminos et al., 2005). Besides 
lipophilicity properties, other important parameters in the make-up of the PS must be 
considered such as the degree of ionization, electric charge, molecular size and non-
specific protein binding (Maisch et al., 2004). 
The driving force for binding of the cationic PS to the negatively charged 
functional groups on the cell surface is of electrostatic nature. Consequently, the binding 
process is completed within a very short time period. Several independent reports 
indicate that extending the pre-irradiation incubation from 5 minutes to 1–2 hours has no 
effect on the amount of PS bound to the microbial cells (Wainwright, 1998; Jori et al., 
2006). 
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PHOTODYNAMIC INACTIVATION OF BACTERIAL CELLS 
BACTERIAL DAMAGES INDUCED BY aPDT: SITES OF ACTION AND PHOTOSENSITIVITY 
Reactive oxygen species can induce cell damages by the following ways: increasing 
ion permeability [Na+/K+] leakage, loss of repair facility, lysis, inhibition of respiration, 
inhibition of ribosome assembly, inhibition of replication, base substitution and strand 
breakage (Wainwright, 1998). Typical type I reactions, for example, at the bacterial 
cytoplasmatic membrane, include the abstraction of allylic hydrogens from unsatured 
molecules such as phospholipids. The radical species thus formed may undergo reaction 
with oxygen to yield the lipid hydroperoxide. Lipid peroxidation is detrimental to 
membrane integrity leading to loss of fluidity and increased permeability (Korytowski et 
al., 1992; Wainwright, 1998). Thus inactivation of membrane enzymes and receptors is 
also possible (Girotti, 1990). The type II reactions are generally accepted as the major 
pathways in photooxidative microbial cell damage (Wainwright, 1998). Singlet oxygen 
also reacts with biomolecules involved in the maintenance and structure of the cell 
wall/membrane such as phospholipids, peptides and sterols (e.g., in yeasts). However, the 
products from such reactions may be slightly different. Whereas type I reaction with 
cholesterol may result in the formation of cholesterol-7α or -7β hydroperoxide, the 
formation of the 5α-isomer is indicative of type II reaction with singlet oxygen (Girotti, 
1990). Reactions of singlet oxygen with other molecules involved in the cell 
wall/membrane also occur (Wainwright, 1998). Nucleic acids are known to react mainly 
through guanosine residues and again there is a difference in selectivity between type I 
and type II photoprocesses.  The type I reaction is mediated through hydroxyl radical 
attack at the sugar moiety whereas the type II reaction is an attack of singlet oxygen at 
guanosine base (Foote, 1990). Some damages produced in the DNA chain can be repaired 
by the action of DNA repairing systems (Imray and MacPhee, 1973). However, some 
authors concluded that although DNA damage occurs, it may not be the main cause of 
bacterial cell death (Hamblin and Hasan, 2004). One argument that has been used in 
favor of this hypothesis is that Deinococcus radiodurans, which is known to have a very 
efficient DNA repair mechanism, is easily killed by aPDT (Schafer et al., 1998; Maisch, 
2009b). 
CHAPTER 1 - INTRODUCTION 
17 
 
While the predominant type of photodynamic action may often be determined by 
the class of the compound, the exact mode of action is also closely governed by the site 
of action. This, in turn, is a function of the physicochemical make-up of the PS 
(Wainwright, 1998). 
Various studies showed that there is a difference in susceptibility to aPDT between 
Gram (+) and Gram (-) bacteria (Nitzan et al., 1992; Merchat et al., 1996b; Minnock et al., 
1996). Anionic and neutral PS were found to bind efficiently to Gram (+) and to induce 
growth inhibition or killing by aPDT. On the other hand, these PS bind only to the outer 
membrane of Gram (-) bacteria, being not killed, showing a remarkable resistance to 
aPDT (Bertoloni et al., 1984; Malik et al., 1990; Bertoloni et al., 1993). The 
photosensitization by neutral and anionic porphyrins of Gram (-) bacteria is possible only 
in the presence of membrane disorganizing substances, such as polymyxin B nonapeptide 
or Tris-EDTA (Nitzan et al., 1992). This is due to the different outer membrane structure of 
Gram (+) and Gram (-) bacteria (Figure 3). Gram (+) bacteria are characterized by the 
presence of a 40-80 nm thick outer peptidoglycan wall with no significant amount of lipids 
or proteins. This murein sacculus contains up to 100 peptidoglycan layers which network 
does not represent a permeability barrier because it is more or less porous. In contrast, 
Gram (-) bacteria contain an additional membrane layer in the cell architecture, which is 
located outside the peptidoglycan layer and shows an asymmetric lipid structure 
composed by strongly negatively charged lipopolysaccharides (LPS), lipoproteins and 
proteins with porin function. Hydrophilic compounds can diffuse through the outer 
membrane using the porins, which are characterized as aqueous channel-forming 
proteins (Nikaido and Vaara, 1985; Yoshimura and Nikaido, 1985). Therefore, the outer 
membrane acts as a very effective permeability barrier, making Gram (-) bacteria resistant 
against host cellular and humoral defense factors. Furthermore, the outer membrane 
triggers mechanisms of resistance against many antibiotics, which are normally sensitive 
to Gram (+) bacteria (Nikaido, 1985; Nikaido, 1994). 
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Figure 3 – Schematic representations of the arrangement of the cell wall of Gram (-) (A) and Gram (+) (B) bacteria 
(Maisch et al., 2004). 
 
In this way, photosensitivity of Gram (-) bacteria with neutral and anionic PS is 
enhanced by the addition of biological or chemical molecules which alter the native 
consistence of the outer membrane, thereby enhancing its permeability and facilitating 
the penetration of phototoxic molecules to the cytoplasmatic membrane (Malik et al., 
1992). The addition of Tris-EDTA to Gram (-) bacteria removes the divalent cations (Ca2+ 
and Mg2+ ions) which are present in large numbers to stabilise adjacent negative charged 
LPS molecules at the outer membrane. Then, the neutralization of negative charges is 
prevented. The onset of electrostatic repulsion promotes the release of up to 50% of the 
LPS into the medium, thereby allowing the penetration of molecules with the molecular 
weights as high as 1000 – 2000 Daltons to the inner cytoplasmic membrane or inner 
cellular compartments (Nikaido and Vaara, 1985). The exposure of Gram (-) bacteria to 
the action of low concentrations of non-toxic polycations (e.g., polymyxin B nonapeptide 
or EDTA) displace divalent cationic counter ions because polymyxin B tends to undergo an 
electrostatic binding with the negatively charged cell surface molecules. By that way, the 
physical arrangement of the ordered lipid layer is heavily altered with less densely packed 
hydrocarbon lipid chains (Vaara and Vaara, 1983). As a result, the barrier properties of 
the outer membrane are strongly reduced and a variety of antibiotics and detergents can 
diffuse towards the plasma membrane (Ayres et al., 1999). 
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Cationic PS have several interesting features which make these compounds 
attractive PS for a variety of biological systems. Studies with cationic porphyrin 
derivatives have shown to photoinduce direct inactivation of both Gram bacteria without 
the presence of an additional permeabilization agent (Lazzeri et al., 2004) probably 
because the cationic sensitizer had a dual action: first in disrupting the bacterial cell wall 
and then in subsequently photosensitizing the cells (Jori and Brown, 2004). Thus, cationic 
PS can be considered as the most promising PS for application as broad-spectrum 
antibacterials (Merchat et al., 1996b; Hamblin et al., 2002; Jori and Brown, 2004; Tomé et 
al., 2004; Jori et al., 2006). 
MECHANISMS OF PHOTOINACTIVATION 
The mechanism of cell photoinactivation may be explained as follows (Figure 4): 
when the PS absorbs light of certain energy it may undergo an electronic transition to the 
singlet excited state (Ps1*). Depending on its molecular structure and environment, the 
molecule may then lose its energy by electronic or physical processes, thus returning to 
the ground state (Ps1), or it may undergo a transition to the triplet excited state (Ps3*) 
(electron spins unpaired). At this stage, the molecule may again undergo electronic decay 
back to the ground state, or it can react further by one or both of two pathways know as 
the type I and type II photoprocesses (Wainwright, 1998; Calin and Parasca, 2009). Type I 
pathway involves electron/hydrogen-transfer reactions from the PS triplet state (PS3*) 
with the participation of a substrate to produce radical ions. The type II pathway involves 
energy transfer from the PS triplet state (PS3*) to molecular oxygen to produce excited-
state singlet oxygen (1O2*). Both of these processes are oxygen dependent and lead to the 
production of highly ROS that can react with biological molecules causing cell disruption 
(De Rosa and Bentley, 2000; Hamblin and Hasan, 2004; Donnelly et al., 2008). It is 
generally accepted that ROS such as 1O2 and reactive oxygen radicals (H2O2, O2-·, HO-·) 
generated by the PS action are the species causing cell disruption (Dougherty et al., 1998; 
Wainwright, 1998; Shackley et al., 1999; Bonnett, 2000; Hamblin and Hasan, 2004). 
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Figure 4 - Photosensitization processes (Wainwright, 1998). 
 
 
A free radical exists with one or more unpaired electron in atomic or molecular 
orbital. Free radicals are generally unstable, highly reactive, and energized molecules. 
Superoxide anion is a reduced form of molecular oxygen produced by receiving 
one electron from the molecular oxygen (O2 + e- → O2-·) (monovalent reduction) 
(Ochsner, 1997; Harman, 2001). The O2-· that receives more than one electron and two 
hydrogen ions forms hydrogen peroxide (2·O2–· + 2H+ → H2O2 + O2) (Stief, 2003). 
Superoxide is not particularly reactive in biological systems and does not cause by itself 
much oxidative damage but it can react with itself by a reaction known as “dismutation” 
to produce highly reactive oxygen intermediates such as hydrogen peroxide and hydroxyl 
radicals (Ochsner, 1997).  
Hydrogen peroxide is the least reactive molecule among reactive oxygen species 
that can be generated through a dismutation reaction from superoxide anion by 
superoxide dismutase. Hydrogen peroxide is highly diffusible and crosses the plasma 
membrane easily. This ROS is stable under physiological pH and temperature in the 
absence of metal ions. It is a weak oxidizing and reducing agent and is thus regarded as 
being poorly reactive (Halliwell, 1997). When H2O2 receives more than one electron and 
one hydrogen ion, the hydroxyl radical is formed (HO-·), which is the most reactive of the 
intermediate ones, once it may react and change any near cellular structure (Jenkins, 
1988). 
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Hydroxyl radical can be formed from superoxide anion and hydrogen peroxide in 
the presence of metal ions such as copper or iron (O2–· + H2O2 → OH· + OH–· + O2). 
Hydroxyl radicals have the highest 1-electron reduction potential and can react with 
everything in living organisms (Korycka-Dahl and Richardson, 1978). 
Because of the high reactivity and short half-life of singlet oxygen and hydroxyl 
radicals, only molecules and structures that are near to the area of its production (areas 
of PS localization) are directly affected by PDT. The half-life of singlet oxygen in biological 
systems is inferior to 40 nanoseconds, and, therefore, the radius of the action of singlet 
oxygen is of the order of 20 nm (Moan and Berg, 1991). 
 
The photodynamic activity to induce cell damage or death is determined by five 
important photophysical/photochemical properties including (Aveline, 2001): 
• an overall lipophilicity and ionization of the photoreactive dyes; 
• the molecular exctinction coefficient, ε; 
• quantum yield of the triplet state formation, ФT; 
• redox potentials of the excited states (singlet and triplet) of the PS, if the 
reaction follows the type I pathway or; 
• the quantum yield of the 1O2 generation, if the reaction occurs by a type II 
photosensitization. 
 
This is important in terms of the preliminary in vitro testing of putative 
compounds: a promising PS in chemical assays may not perform well against its microbial 
target due to metabolism, reduction and other factors or simply because it localizes in a 
non-vital region of the target cell. The reverse may also occur: the triphenylmethane dye 
crystal violet (gentian violet) shows no photosensitizing behavior in chemical tests, yet its 
inherent bactericidal activity is enhanced by illumination (Wilson et al., 1992). This is 
thought to result from intracellular adsorption of the PS causing rigidity of its structure 
and inhibition of the rotational energy loss from the singlet excited state. This leads to 
increases in the triplet-state yield and thus in the photosensitizing efficacy (Oster, 1955). 
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METHODS TO DETERMINE THE PHOTOINACTIVATION PROCESS: SINGLET OXYGEN 
QUENCHERS AND FREE RADICAL SCAVENGERS 
It is important to consider some of the strategies to distinguish between type I 
and type II mechanisms in the PI process. The simplest approach for determining whether 
1O2 or another ROS are involved in a photoinactivation process is to investigate the 
inhibitory effects of various scavengers, i.e., compounds that can intercept these species 
at high rates and in a putatively selective manner (Girotti, 2001). Some studies were 
carried out in order to determine which mechanism(s) is(are) responsible for the PI 
process but only few studies were carried out using MO, namely bacterial cells, and 
scavengers (Table 2). Others investigations employed chemical techniques without the 
use of biological systems and/or scavengers (O´Brien et al., 1992; Egorov et al., 1997; 
Hadjur et al., 1998; Wei et al., 2006; Baier et al., 2007; Maisch et al., 2007; Ribeiro et al., 
2007; Magalhães et al., 2008). 
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Table 2 – Studies using free radical scavengers and singlet oxygen quenchers to determine the photoprocess(es) 
involved in the inactivation of some microorganisms. 
BACTERIA 
Microorganisms PS 
Free radical 
scavengers 
Singlet oxygen 
quenchers 
Results Reference 
Staphyloccocus 
aureus 
Deutero-
porphyrin 
Propylgallate 
Methionine 
Tryptophan 
1,4-
diazabicyclo- 
2,2,2-octane 
(DBCO) 
Both type I 
and type II 
mechanisms 
(Nitzan et al., 1989) 
Escherichia coli TiO2 
Tert-butanol 
Methanol 
 
Type I 
mechanism 
(Cho et al., 2005) 
Escherichia coli 
 
(UV and 
simulated 
sunlight) 
Mannitol 
Superoxide 
dismutase 
Cysteine 
Ascorbate 
Pyruvate 
Catalase 
Histidine 
Type I 
mechanism 
(Khaengraeng and 
Reed, 2005) 
Vibrio vulnificus 
Toluidine 
blue O 
Proline Tryptophan 
Both type I 
and type II 
mechanisms 
(Wong et al., 2005) 
Enterococcus 
hirae 
Escherichia coli 
 
Meso-tetra 
(N-methyl-4-
pyridyl) 
porphyrin 
tetra-tosylate  
Superoxide 
dismutase 
Catalase 
Dimethyl sulfoxide  
Sodium azide 
Histidine 
β-carotene 
Both type I 
and type II 
mechanisms  
(Ergaieg et al., 
2008) 
Staphylococcus 
aureus 
 
(UV) 
Ascorbic acid 
Catalase 
Dimethyl-thiourea 
 
Type II 
mechanism 
(Maclean et al., 
2008) 
Staphylococcus 
aureus 
Indocyanine 
green 
 
Tryptophan 
Deuterium 
oxide 
(enhancer of  
Type II 
mechanism 
(Omar et al., 2008) 
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   the life span of 
1O2) 
  
Staphylococcus 
aureus 
Methylene 
blue 
Mannitol 
Tryptophan 
Sodium azide 
Type I 
mechanism 
(Sabbahi et al., 
2008) 
VIRUSES 
Microorganisms PS 
Free radical 
scavengers 
Singlet oxygen 
quenchers 
Results Reference 
Phages J1, δA, 
MS2 and Φ6 
Ascorbic acid 
1,2-
dihydroxybenzene-
3,5-disulfonic acid 
Potassium bromide 
Potassium iodide 
Potassium 
thiocyanate 
Sodium formate 
1,4-
diazabicyclo[2.
2.2]octane 
Sodium azide 
Guanosine 
β-carotene 
Type I 
mechanism 
(Murata et al., 
1986) 
Herpes simplex 
virus type I 
Suid herpes virus 
type I 
3,3'-(1,4-
naphthyli-
dene)dipro-
pionate 
Mannitol 
Glycerol 
Superoxide 
dismutase 
Imidazol 
Histidine 
Sodium azide 
Type I and 
type II 
mechanisms(
mainly type  
II 
mechanism) 
(Müller-Breitkreutz 
et al., 1995) 
M13  
bacteriophage 
Metylene 
blue 
 
(Presence of free 
radicals determined 
chemically) 
Sodium azide 
Both type I 
and type II 
mechanisms 
(Abe et al., 1997) 
T7 phage 
5,10,15-(4-h-
D-galacto 
sylphenyl), 
20-(2V,3V, 
4V,5V-penta- 
fluorophenyl)
porphyrin 
1,3-dimethyl-2-
thiourea 
Sodium azide 
Both type I 
and type II 
mechanisms 
(Egyeki et al., 2003) 
MS-2 phage TiO2 
Tert-butanol 
Methanol 
 
Type I 
mechanism 
(Cho et al., 2005) 
 
CHAPTER 1 - INTRODUCTION 
25 
 
The nature of the quenching reaction in a specific PS/quencher pair may vary with 
the wavelength of photoexcitation, chemical nature of the solvent, oxygen partial 
pressure and many other physicochemical factors (Wondrak et al., 2005). 
Sodium azide and histidine are commonly used to determine the singlet oxygen 
oxidation of compounds. These agents act as quenchers of singlet oxygen and greatly 
suppress the activity and consumption of singlet oxygen (Song et al., 1999). Singlet 
oxygen quenching by sodium azide seems to be a charge transfer process in which 
molecular triplet oxygen is released after the reaction, therefore no oxygen is consumed 
(Telfer et al., 1994). The specificity of cholesterol makes its use as an effective indicator of 
singlet oxygen oxidation, in situ, where the use of other detection techniques is difficult 
(Girotti, 1998; Girotti and Korytowski, 2000). Enhancement of oxygen consumption in 
deuterium oxide, relative to water, is often used as an indicator of the involvement of 
singlet oxygen in oxidation due to the increased half-life of singlet oxygen in deuterium 
oxide (Athar et al., 1988; Pecci et al., 2000). Several other quenching agents have 
specificity for singlet oxygen: β-carotene, imidazole, α-tocopherol, tryptophan (Trp), 
reduced glutathione (Murata et al., 1986; Perotti et al., 2002) and others. 
Most free radical scavengers are antioxidants, compounds that neutralize free 
radicals by donating a hydrogen atom (with its one electron) to the radical. Antioxidants, 
therefore, reduce free radicals and are themselves oxidized in the reaction (Lieberman 
and Marks, 2008). Antioxidant enzymes, including superoxide dismutase and catalase, 
convert free radicals into non-reactive oxygen molecules. Superoxide dismutase converts 
superoxide anion into hydrogen peroxide and oxygen. Catalase is involved in cellular 
detoxification and can convert hydrogen peroxide into water and oxygen. Glutathione 
peroxidase is the most important hydrogen peroxide–removing enzyme existing in the 
membrane (Papas, 1999). Non-enzymatic antioxidants have a common structural feature: 
a conjugated double bond system that may be an aromatic ring. Vitamin E (α-tocopherol) 
is a lipid-soluble antioxidant vitamin that functions is principally to protect against lipid 
peroxidation in membrane. When vitamin E donates hydrogen to a lipid peroxyl radical, it 
is converted to a free radical form that is stabilized by resonance. Due to his chemistry, 
the vitamin E has a greater tendency to donate a second electron and go to the fully 
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oxidized form (Lieberman and Marks, 2008). Although ascorbic acid is an oxidation-
reduction coenzyme that functions in collagen synthesis and other reactions, it also plays 
a role in free radical defense. Reduced ascorbate can regenerate the reduced form of 
vitamin E by donating electrons in a redox cycle (Lieberman and Marks, 2008). The 
antioxidant activity of cysteine is due to its sulphydryl group, acting as the free radical 
scavenger, and thus as the antioxidants, in biological and other systems (Taylor and 
Richardson, 1980). Several other quenching agents have specificity for free radicals: 
melanin (Wang et al., 2008), tert-butanol, methanol (Cho et al., 2005), mannitol, 
glutathione, melatonin (Perotti et al., 2002), dimethyl sulfoxide (DMSO) (Ergaieg et al., 
2008), and others.  
It is important to determine the PI process of each new PS produced in order to 
know how the PI occurs in the microbial cell. As the efficiency of microbial PI depends on 
the amount of singlet oxygen (type II mechanism) and/or of free radicals (type I 
mechanism) produced during the PI process, it is important to know which of these ROS 
are generated in order to improve the design of the PS and to improve the design of the 
photodynamic experiments. 
 
BACTERIAL RESISTANCE TO PHOTOINACTIVATION 
Only few studies were done in order to determine if bacterial resistance occurs 
after various treatments of aPDT. The studies concerning aPDT are more focused on the 
identification of new PS that kill rapidly and efficiently the MO and to determine the 
mode of inactivation of the PS. However, and regarding the appearance of bacterial 
resistance to antimicrobial drugs, it is important to control the process of PI in terms of 
resistance. Lauro et al. (2002) investigated the selection of resistant bacterial strains in 
Peptostreptococcus micros and Actinobacillus actinomycetemcomitans after repeated 
photosensitization of surviving cells with the porphycene-polylysine conjugates 2,7,12,17-
tetrakis(2-methoxyethyl)-9-glutaramidoporphycene (GlamTMPn) and 2,7,12,17-
tetrakis(2-methoxyethyl)-9-p-carboxybenzyloxyporphycene (BOHTMPn). The results 
obtained by this group show that the photosensitization of P. micros and A. 
actinomycetemcomitans by both GlamTMPn and BOHTMPn induce no appreciable 
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development of resistance in partially inactivated bacterial cells. In fact, the efficiency of 
photokilling underwent no change in ten subsequent irradiation sessions, even though 
cells which were damaged in a previous treatment were cultivated and reexposed to 
porphycene and light (Lauro et al., 2002). Jori et al. (unpublished data) determined that 
up to five consecutive generations of extensively photoinactivated MRSA (ca. 90%) show 
essentially identical degrees of sensitivity to phthalocyanine photosensitization (Jori and 
Coppellotti, 2007). Moreover, Winckler (2007) affirmed that cell wall structures and 
membranes are the main target of PDT drugs, and so the drugs do not necessarily need to 
enter the cell. Specific and proper adhesion to these structures are sufficient for light-
activated destruction of the target cell. Thus target cells have no chance to develop 
resistance by stopping uptake, increasing metabolic detoxification or increasing export of 
the drug (Winckler, 2007). Various authors refer that resistance to aPDT do not occur 
after repeated treatments having in consideration for this purpose the damages that can 
occur in the MO after a process of PI, using none experimental support that tests the 
efficiency of PI after several treatments (Ito and Kobayashi, 1977; Bagchi and Sreeradha, 
1989; Bhatti et al., 1998; Carré et al., 1999; Hamblin and Hasan, 2004; Winckler, 2007; 
Donnelly et al., 2008; Omar et al., 2008; Cassidy et al., 2009). Bacteria replicate very 
rapidly and mutations in microbial population occur occasionally. For this reason, it is 
essential to monitor the PDI process in order to control if mechanisms of resistance occur 
as a result of microbial evolution and not having only into account the kind of damages 
that could not induce resistance to aPDT.   
 
RAPID METHODS TO MONITOR THE aPDT PROCESS IN BACTERIA 
To monitor the bacterial PI process, faster methods are required instead of the 
laborious conventional methods of plating, overnight incubation and time-consuming 
counting of colony-forming units (CFU) (Vesterlund et al., 2004; Demidova and Hamblin, 
2005; Alves et al., 2008). New approaches to study potential PS in vitro are essential to 
accelerate the development of aPDT to evaluate which PI pathway is most important and 
to determine the potential development of mechanisms of resistance. 
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To this end, the bacterial bioluminescence method is considered to be a rapid 
(Hamblin et al., 2002), sensitive (Francis et al., 2001) and cost-effective option (Vesterlund 
et al., 2004). Moreover, it allows only living or viable cells to be detected and does not 
need exogenous administration of substrates to obtain light emission (Rocchetta et al., 
2001). 
Bioluminescence refers to the process of visible light emission in living organisms 
mediated by an enzyme catalyst (Meighen, 1993). The light emission is directly 
dependent on the metabolic activity of the organism (Vesterlund et al., 2004), once an 
inhibition of cellular activity results in a decrease in the respiration rate and consequently 
a decrease in the bioluminescence rate. The phenomenon of bioluminescence has been 
observed in many different organisms including bacteria, fungi, fish, insects, algae and 
squid (Meighen, 1993). Luminous bacteria constitute some of the most fascinating 
subjects in microbiology and are much more prevalent than is frequently appreciated. 
They are found in marine, freshwater and terrestrial environments (Stewart and Williams, 
1992). 
The enzymes that catalyze the bacterial bioluminescent reaction are called 
luciferases and the substrates are fatty acids. Luciferase consists on an oxygenase that 
catalyzes the emission of light (Ziegler and Baldwin, 1981). The light-emitting reaction 
involves the oxidation of reduced riboflavin phosphate (FMNH2) and a long chain fatty 
aldehyde with the emission of blue-green light (Figure 5) (Engebrecht et al., 1983; 
Rodriguez et al., 1985; Meighen, 1993). 
 
Figure 5 – Substrates, products and pathways involved in the bacterial bioluminescence reaction (Engebrecht et al., 
1983). 
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In both marine and terrestrial bioluminescent bacteria, a five genes operon 
(luxCDABE) encodes the luciferase and biosynthetic enzymes (for the synthesis of the 
aldehyde substrate) necessary for light production. luxA and luxB genes encode the alpha 
and beta subunits of the luciferase, with luxC, luxD and luxE genes encoding proteins for 
aldehyde production (Meighen, 1991). 
The emission of light by most luminescent bacteria is highly dependent on the 
extent of cellular growth. During the initial stages of growth at low cell density, the lux 
genes are not expressed and luminescence in a cell culture will actually decrease with 
growth, primary due to a limitation in substrates for the luminescent reaction. During mid 
to late logarithmic growth, depending on the species and the nutrient composition of 
growth medium, light emission will increase dramatically. The increase in luminescence 
arises by activation of expression of the genes in the lux operon including the luxCDABE 
genes. Although a number of additional lux genes in bioluminescent bacteria have been 
identified, only luxCDABE are essential for the biosynthetic production of light (Meighen, 
1993). In marine bioluminescent bacteria light emission occurs preferentially at 
temperatures below 30°C (Hill et al., 1993). 
Light output from these bioluminescent bacteria is a highly sensitive reporter of 
metabolic activity (Marincs, 2000) and can therefore be used to monitor the real-time 
effects of antimicrobials on bacterial metabolism (Salisbury et al., 1999; Rocchetta et al., 
2001). Moreover, in experimental systems in which a strong correlation between 
bioluminescence and viable counts can be demonstrated, measurement of 
bioluminescence offers a rapid, alternative method for monitoring bacterial viability 
(Marincs, 2000; Rocchetta et al., 2001; Alves et al., 2008). Light output is noncumulative, 
reflecting actual metabolic rate, and can be measured directly, continuously and non-
destructively in high-throughput screening or continuous-culture models (Beard et al., 
2002). 
With the development of recombinant DNA technology, the phenomenon of 
bacterial bioluminescence can now be captured and applied within any bacterial species 
from several rather different perspectives. It provides a real-time non-invasive reporter 
for measuring gene expression, a sensitive marker for bacterial detection and a measure 
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of intracellular biochemical function, i.e. as a holistic determinant of cellular viability 
(Stewart and Williams, 1992).  Amongst the applications of these recombinant bacteria, 
the clinical (Contag et al., 2000; Rocchetta et al., 2001; Jawhara and Mordon, 2004; 
Demidova et al., 2005; Doyle et al., 2006), environmental (Burlage et al., 1990; Ptitsyn et 
al., 1997; Verschaeve et al., 1999; Johnson, 2005; Grande et al., 2007; Alves et al., 2008) 
and biotechnological research (Maoz et al., 2002; Kadurugamuwa et al., 2003) are the 
most promising ones. 
 
OBJECTIVES AND THESIS OUTLINE 
The aim of this thesis is to study the mechanism(s) involved in the photodynamic 
inactivation of bacteria using meso-substituted cationic porphyrin derivatives as 
photosensitizers and a recombinant bioluminescent Escherichia coli as the bacterial 
model in order to use a rapid, sensitive and cost-effective method to monitor the process, 
instead of conventional laborious methods of dilution, plating and colony counting.  
Bacterial viability recovery and resistance studies after aPDT treatments will be also 
carried out using two Gram (-) bacteria: Vibrio fischeri and recombinant bioluminescent 
Escherichia coli. 
Chapter 1 consists on a broad introduction, focusing on the photodynamic 
therapy, the antimicrobial photodynamic therapy, the mechanisms of photodynamic 
inactivation and the use of a new method to run the aPDT studies. 
Chapter 2 describes the work done using the recombinant bioluminescent E. coli 
to determine which photoprocess(es) is(are) implicated in bacterial inactivation by the 
porphyrin derivatives tested, using different inhibitors of the photodynamic process. 
Chapter 3 describes the assessment of bacterial viability recovery and of bacterial 
resistance to aPDT, using bioluminescent V. fischeri and E. coli as bacterial models, a 
meso-substituted cationic porphyrin derivative as photosensitizer and artificial white light 
as light source. 
Chapter 4 discusses the obtained results and presents the main conclusions. 
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MECHANISMS OF PHOTODYNAMIC INACTIVATION OF A GRAM-NEGATIVE 
RECOMBINANT BIOLUMINESCENT BACTERIUM BY CATIONIC PORPHYRINS 
 
 
ABSTRACT 
With the emergence of antibiotic resistances by microorganisms it is extremely important 
to develop alternative treatments for microbial infections. The use of photodynamic therapy as a 
non-invasive approach to destroy pathogenic microorganisms seems to be very promising. Two 
oxidative mechanisms are considered to be mainly implicated in the photodamage of cells. In this 
study, we aim to identify which mechanism(s) is(are) responsible for the photoinactivation of a 
bioluminescent recombinant Escherichia coli by three cationic porphyrins using a rapid method 
based on the monitoring of the metabolic activity of this bacterium. The inhibitory effect of the 
photodynamic process was evaluated by exposing bacterial suspensions of 105 RLU mL-1, in the 
presence of singlet oxygen quencher or free radical scavengers, to white light (4 mW cm-2), for 
270 minutes, to the photosensitizers (0.5 µM of Tri-Py+-Me-PF, 5.0 µM of Tetra-Py+-Me and 5.0 
µM of Tri-SPy+-Me-PF). Sodium azide (100 mM) was used as singlet oxygen quencher, and D-
mannitol (100 mM) and L-cysteine (100 mM) were used as free radical scavengers. Tri-Py+-Me-PF 
and Tetra-Py+-Me, in the presence of sodium azide, only led to 0.8 and 1.0 log reduction on E. coli 
bioluminescence, respectively. However, in the presence of L-cysteine and D-mannitol the 
reduction on bacterial bioluminescence was significantly higher (5.8 and 5.4 log units for Tri-Py+-
Me-PF and 6.0 log units with both scavengers for Tetra-Py+-Me) when compared with 6.1 and 6.2 
log reduction obtained for E. coli exposed to Tri-Py+-Me-PF and Tetra-Py+-Me without scavengers, 
respectively. The results obtained with Tri-SPy+-Me-PF are unexpected and quite different from 
those with Tri-Py+-Me-PF and Tetra-Py+-Me. Reductions of 0.2, 0.7 and 3.2 log units were achieved 
in the presence of sodium azide, L-cysteine and D-mannitol, respectively. However, the high 
inhibition of PS activity by L-cysteine is not due to scavenger of free radical but due to a direct 
inhibition of the PS by the scavenger. In fact, the Tri-SPy+-Me-PF does not produce 1O2 in the 
presence of L-cysteine. The results obtained in this study suggest that singlet oxygen (type II 
mechanism) plays a very important role over free radicals (type I mechanism) on the 
photoinactivation process of the bioluminescent E. coli by Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-
SPy+-Me-PF. Although the use of scavengers is an adequate and simple approach to evaluate the 
relative importance of the two pathways, it is essential to have into account that the scavengers 
must be chosen having in consideration the structure of the photosensitizer. 
 
Keywords Antimicrobial photodynamic therapy; cationic porphyrins; reactive oxygen species; mechanisms 
of photoinactivation; bioluminescence; Escherichia coli 
 
INTRODUCTION 
The emergence of antibiotic resistance amongst pathogenic bacteria is bringing to 
an end a period extending over the past 50 years (Yoshikawa, 2002). Bacteria replicate 
very rapidly and a mutation that helps a microbe to survive in the presence of an 
antimicrobial drug will quickly become predominant throughout the microbial population 
(Hamblin and Hasan, 2004; Woodford and Ellington, 2007). The inappropriate 
prescription of antibiotics and the failure of some patients to complete their treatment 
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regimen also intensify the problem (Hamblin and Hasan, 2004). The resistance 
mechanisms developed by pathogenic bacteria in the last decades has led to a major 
effort to find alternative antimicrobial agents, preferentially faster, more efficient, non-
invasive and non-toxic to treat microbial infections, which would not lead to microbial 
resistance (Sommer et al., 2000; Taylor et al., 2002; Hamblin and Hasan, 2004; Jori et al., 
2006; Calin and Parasca, 2009).  
The use of photodynamic therapy (PDT) as a non-antibiotic approach to inactivate 
pathogenic MO seems to be very promising (Jori and Perrin, 1985; Konig et al., 2000; 
Stojiljkovic et al., 2001). Antimicrobial photodynamic therapy (aPDT) approach is based on 
the PDT concept, in which a photosensitizer (PS) localized preferentially in target cells 
(e.g., tumour cells, skin cells, MO), when activated by low doses of visible light at an 
appropriate wavelength, generates cytotoxic species (singlet oxygen and free radicals) 
that destroy those cells (Wainwright, 1998; Bonnett, 2000; Wainwright, 2000; Maisch, 
2009b). Two oxidative mechanisms of inactivation are considered to be implicated in 
aPDT (Figure 6). After the absorption of the photon by the PS it passes from the ground 
state (PS1) to its first excited state (PS1*). From this state, the PS can return again to the 
ground state (PS1) or it can pass into a triplet excited state (PS3*). From this triplet excited 
state, the PS can return to the ground state (PS1) or it can react further by one or both of 
the two pathways known as the type I and type II photoprocesses (Calin and Parasca, 
2009). Type I pathway involves electron-transfer reactions from the PS triplet state (PS3*) 
with the participation of a substrate to produce radical ions. The type II pathway involves 
energy transfer from the PS triplet state (PS3*) to molecular oxygen to produce excited-
state singlet oxygen (1O2*) (Ochsner, 1997; De Rosa and Bentley, 2000; Hamblin and 
Hasan, 2004; Donnelly et al., 2008). Both of these processes are oxygen dependent and 
lead to the formation of highly toxic reactive oxygen species (ROS). These ROS can readily 
react with biological molecules including cholesterol, unsaturated fatty acids in lipid 
layers of membranes, amino acid residues such as cysteine, histidine, and tryptophan 
(Trp) of protein structures, as well as nucleic acid bases of DNA, particularly guanine and 
thymine, and therefore can lead to a loose of appropriate biological functionality 
producing cell inactivation (Ochsner, 1997; Girotti, 2001; Dolmans et al., 2003).  
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Figure 6 – Photosensitization processes (adapted from Wainwright, 1998). 
 
The use of singlet oxygen quenchers (e.g., sodium azide, histidine, cholesterol, β-
carotene, imidazole, α-tocopherol, Trp and reduced glutathione) and of free radicals 
scavengers (e.g., superoxide dismutase, catalase, mannitol, glutathione, melatonin, α-
tocopherol and cysteine) represents a simple approach to determine which pathway(s) 
is(are) involved in the photodynamic inactivation (Taylor and Richardson, 1980; Murata et 
al., 1986; Girotti, 1998; Papas, 1999; Song et al., 1999; Girotti and Korytowski, 2000; 
Girotti, 2001; Perotti et al., 2002; Lieberman and Marks, 2008). 
According to the literature, singlet oxygen plays an important role in the 
photodynamic process and, consequently, the quantum yield of singlet oxygen is a useful 
parameter to determine the phototherapeutic activity of the PS. Some studies show that 
type I mechanisms may be equally or even more important than type II pathway. 
Although these experimental works report which 1O2 or radicals pathways are involved in 
the photoinactivation (PI) reaction, there are only few studies using MO, namely bacterial 
cells and scavengers. The inactivation mechanism of Staphylococcus aureus by 
deuteroporphyrin (DP) with singlet oxygen quenchers or hydroxyl radical scavengers was 
investigated by Nitzan et al. (1989). The light-activated DP (10 µM mL-1) reduced the 
viability of the culture to less than 1%, whereas methionine, Trp, and 1,4-diazabicyclo-
2,2,2-octane (DBCO) used as singlet oxygen quenchers provided almost 60% protection. 
Propylgallate, which is a hydroxyl free radical scavenger, also provided 60% protection. 
The presence of a singlet oxygen quencher and propylgallate provided almost complete 
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protection from inactivation (96%). The results obtained by this group indicate that S. 
aureus PI by DP is mediated by both singlet oxygen and free radicals pathways (Nitzan et 
al., 1989). Wong et al. (2005) demonstrated that using the free radical scavenger proline 
and the singlet oxygen quencher Trp, lead to the antibacterial effect of toluidine blue O 
(TBO) on Vibrio vulnificus was markedly reduced indicating that both free radicals and 
singlet oxygen play an important role on the PI of V. vulnificus with TBO (Wong et al., 
2005). According to Maisch et al. (2005), when methicillin-resistant S. aureus (MRSA) 
(ATCC BAA-44) was incubated with 0.005 µM of porphyrin XF73 alone or in the presence 
of 5 mM of the singlet oxygen quencher sodium azide, the survival of MRSA cells 
increased from 0.015% ± 0.01% to 8.6% ± 0.2% compared to that with incubation with 
XF73 alone after 15.2 mW cm-2 of light irradiation (Maisch et al., 2005). In another study, 
it was investigated the mechanism of PI of S. aureus by methylene blue (MB) using 
sodium azide and Trp as singlet oxygen quenchers, and mannitol as a hydroxyl free radical 
scavenger. When the bacterium was treated with MB (20 µM) exposed to 50 mW cm-2 of 
visible light during 10 minutes, it was found that the survival fraction had decreased 
dramatically to about 31.27 ± 5.39% without quenchers. The presence of sodium azide 
and Trp failed to show any protection from the MB photodynamic activity. However, in 
the presence of mannitol, the activity of MB was inhibited, reaching a protection level of 
about 27%, concluding that the photodynamic activity of MB occurred in part via type I 
mechanism (Sabbahi et al., 2008). Ergaieg et al. (2008) studied the mechanism involved in 
the phototoxicity of the cationic porphyrin meso-tetra (N-methyl-4-pyridyl) porphyrin 
tetra-tosylate (TMPyP) on Enterococcus hirae and on Escherichia coli using specific 
scavengers and quenchers of ROS. They showed that using sodium azide, histidine and β-
carotene as singlet oxygen quenchers, reductions on the PI activity of E. hirae and E. coli 
cells were obtained. Furthermore, using the free radical scavengers superoxide 
dismutase, catalase and dimethyl sulfoxide (DMSO) they also obtained an important 
reduction on the activity of TMPyP concluding that both type I and type II reactions play 
an important role on the PI process of both bacteria using the mentioned porphyrin 
(Ergaieg et al., 2008).  
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To monitor the mechanism of bacterial PI, faster methods are required instead of 
the laborious and time-consuming conventional methods of serial dilutions, plating, 
overnight incubation and counting of colony-forming units (CFU). New approaches are 
essential to accelerate the development of aPDT, namely to evaluate which mechanism(s) 
is(are) responsible for the PI process. The bacterial bioluminescence method, when 
applied to PI studies to monitor in real-time the bacterial viability, is considered to be a 
rapid, sensitive and cost-effective option (Hamblin et al., 2002; Demidova and Hamblin, 
2005; Alves et al., 2008). In experimental systems, a strong correlation between 
bioluminescence and viable counts can be demonstrated (Marincs, 2000; Rocchetta et al., 
2001; Alves et al., 2008). The light output is noncumulative, reflecting actual metabolic 
rate, and can be measured directly, continuously and non-destructively in high-
throughput screening or continuous-culture models (Beard et al., 2002).  
 The aim of this study is to identify which mechanism(s) is(are) responsible for the 
PI of a bioluminescent recombinant E. coli using three cationic meso-substituted 
porphyrin derivatives as PS and a rapid detection method based on the metabolic activity 
of the strain. 
 
MATERIALS AND METHODS 
 
PHOTOSENSITIZERS 
The porphyrins used in this work were prepared in two steps according to the 
literature (Tomé et al., 2004). In the first step, the neutral porphyrins were synthesized by 
the crossed Rothemund reactions using pyrrole and the adequate benzaldheydes at reflux 
in acetic acid and nitrobenzene. The resulting porphyrins were separated by column 
chromatography (silica) and pyridyl groups quaternized by reaction with methyl iodide. 
Porphyrins were purified by crystallization from chloroform/methanol/petroleum ether 
and their purities were confirmed by thin layer chromatography and by 1H NMR 
spectroscopy. The three PS used were 5,10,15-tris(1-methylpyridinium-4-yl)-20-
(pentafluorophenyl)porphyrin tri-iodide (Tri-Py+-Me-PF), 5,10,15,20-tetrakis(1-
methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py+-Me) and 5-(pentafluorophenyl)-
10,15,20-tris[2,3,5,6-tetrafluoro-4-(1-methylpyridinium-4-ylsulfanyl)phenyl]porphyrin tri-
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iodide) (Tri-SPy+-Me-PF) (Figure 7). Stock solutions of 500 µM of all porphyrins (dissolved 
in DMSO) were prepared and then maintained at 4°C. 
 
 
Figure 7 – Structure of the three porphyrin derivatives. 
 
 
BACTERIAL STRAIN AND BACTERIAL GROWTH CONDITIONS 
Bioluminescent E. coli was transformed in a previous work and stored at -80°C in 
10% of glycerol (Alves et al., 2008). For the transformation, the plasmids pHK724 and 
pHK555 were inserted into competent cells of E. coli Top 10 (Invitrogen, USA), resulting in 
a bioluminescent strain. These plasmids contain the lux operon, required to produce light, 
from the bioluminescent marine bacterium Vibrio fischeri (Alves et al., 2008).  
Before each assay, an aliquot of bioluminescent bacteria stored at -80°C in 10% of 
glycerol was aseptically plated on tryptic soy agar (TSA, Merck) with 100 mg mL-1 of 
ampicilin (Amp) and 25 mg mL-1 of chloramphenicol (Cm) and grown for one day at 37°C. 
Next, one isolated colony was aseptically inoculated on tryptic soy broth (TSB, Merck) 
with both antibiotics and grown for one day at 25°C under stirring (100 rpm). Afterward, 
an aliquot of this culture was subcultured in 30 mL of TSB with Amp and Cm and grown 
overnight at 25°C, under 100 rpm stirring, to reach the stationary growth phase 
(OD600≈1,3) (Alves et al., 2008). 
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BIOLUMINESCENCE VERSUS CFU 
To evaluate the correlation between the CFU and the bioluminescence signal of E. 
coli, two assays were carried out in dark conditions, with and without porphyrin (Tri-Py+-
Me-PF). Two bacterial suspensions (≈ 107 CFU mL-1) were prepared from an overnight 
culture of bioluminescent E. coli, diluting the culture 1:10 in fresh phosphate buffered 
saline (PBS) 1x (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4 per liter; pH 7.4). In 
one of these bacterial suspensions, the porphyrin (5.0 µM) was added and an incubation 
was performed in dark conditions during 4 hours at 25-28°C, under stirring. Next, both 
suspensions were serially diluted (10-1 - 10-7) in PBS. Non-diluted (100) and diluted aliquots 
were pour plated on TSA medium (1 mL) and, simultaneously, were read on a 
luminometer (500 µL) (TD-20/20 Luminometer, Turner Designs, Inc., USA) to determine 
the bioluminescence signal (measured in relative light units – RLU).  
A PI assay was done in order to confirm the correlation between the CFU and the 
bioluminescence signal. Bacterial cultures grown overnight were diluted in PBS and 
bacterial suspensions were equally distributed in 600 mL sterilized and acid-washed glass 
beakers. Then, the appropriate volume of the Tri-Py+-Me-PF porphyrin was added to 
achieve the final concentration of 5.0 µM (total volume was 15 mL per beaker). Dark and 
light controls were carried out during the experiment. The samples were protected from 
light with aluminum foil and incubated for 10 min under 100 rpm stirring, at 25-28°C, to 
promote the porphyrin binding to E. coli cells. Then, the mixtures were exposed to white 
light (4 mW cm-2) for 270 minutes (corresponding to a light fluence of 64.8 J cm-2). 
Aliquots of treated and control samples were collected at time 0 and after 60, 90, 180 and 
270 minutes of light exposure and pour plated on TSA. Simultaneously, the aliquots were 
read on the luminometer to determine the bioluminescence signal.  
Both experiments were done in duplicate and the results were averaged. 
 
EXPERIMENTAL SETUP 
Cultures of bioluminescent E. coli grown overnight in TSB with Amp and Cm were 
diluted in PBS to achieve a final concentration of 107 CFU mL-1 (corresponding, 
approximately, to 105 RLU). This bacterial suspension was equally distributed in 600 mL 
sterilized and acid-washed beakers. Afterwards, the appropriate volume of porphyrin was 
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added to the respective beaker to achieve the following final concentrations: 0.5 µM of 
Tri-Py+-Me-PF, and 5.0 µM of Tetra-Py+-Me and Tri-SPy+-Me-PF (total volume was 15 mL 
per beaker). Then, inhibitors of both PI processes were also added. To test type I 
mechanism, the free radical scavengers L-cysteine (100 mM) and D-mannitol (100 mM) 
were used. To test type II mechanism, sodium azide (100 mM) was used as singlet oxygen 
quencher. Different concentrations of different inhibitors were previously tested and the 
best concentration was used to study the mechanisms of PI (data not shown). Light and 
dark controls were included in all experiments. The samples were protected from light 
with aluminum foil and incubated for 10 min under 100 rpm stirring (25-28°C). Then, the 
mixtures were exposed to white light (4 mW cm-2) for 270 minutes. Aliquots of treated 
and control samples were collected at time 0 and after 30, 60, 90, 120, 150, 180, 225 and 
270 minutes of light exposure and the bioluminescence signal was measured in the 
luminometer. 
All experiments were done in duplicate and the results were averaged. 
 
IRRADIATION CONDITIONS 
The evaluation of inactivation mechanisms of the cationic porphyrins was 
assessed by exposing bioluminescent E. coli in laboratory conditions to white light (PAR 
radiation, 13 lamps OSRAM 21 of 18 W each one, 380–700 nm) with a fluence rate of 4 
mW cm-2 (measured with a radiometer LI-COR Model LI-250). As the V. fischeri lux genes 
inserted into E. coli make them emit light at temperatures below 30°C (Stewart and 
Williams, 1992; Hill et al., 1993), the beakers were placed on a tray with water in order to 
maintain the samples at a constant temperature (25-28°C).  
 
SINGLET OXYGEN GENERATION AND PHOTOSTABILITY STUDIES 
Stock solutions of each porphyrin were prepared at 0.1 mM in dimethylformamide 
(DMF): water (9:1) and a stock solution of 1,3-diphenylisobenzofuran (DPiBF) at 10 mM in 
DMSO. The reaction mixture of 50 μM of DPiBF and 0.5 μM of the porphyrin derivative in 
DMF/water (9:1) in glass cells (2 mL) was irradiated with white light, filtered through a 
cut-off filter of wavelength < 550 nm, at a fluence rate of 9 mW cm-2. During the 
irradiation period, the solutions were stirred at room temperature. The generation of 
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singlet oxygen was followed by its reaction with DPiBF. The breakdown of DPiBF was 
monitored by measuring the decreasing of the absorbance at 415 nm at irradiation 
intervals of 1 min. 
To determine the possible influence of the free radical scavengers L-cysteine and 
D-mannitol on the activity of the PS tested, singlet oxygen generation assays were done as 
described before, but adding an appropriate quantity of the scavenger to the PS, from 
stock solutions of 50 mM. The breakdown of DPiBF was observed by measuring the 
diminishing of the absorbance at 415 nm at irradiation intervals of 15 to 60 seconds. 
The photostability of the photosensitizers was determined by irradiating 2 mL of 1 
μM solutions of the porphyrins in DMF/water (9:1) with white light (under the same 
conditions as those used for the irradiation of the experimental samples). During such 
irradiation the solutions were magnetically stirred and kept at room temperature. At fixed 
intervals of time (0; 1; 3; 6; 10; 15; 25; 40; 60; 90; 135; 195; 270 min), the absorbance of 
the tested porphyrins was determined by visible absorption spectrophotometry at the 
Soret band. 
 
RESULTS 
BIOLUMINESCENCE VERSUS CFU 
It was observed a linear correlation between viable counts and the 
bioluminescence signal of overnight cultures of bioluminescent E. coli (Figure 8). This 
relationship is similar in the absence and in the presence of PS. The correlation obtained 
between bioluminescence signal and viable counts showed that 107 CFU mL-1 correspond, 
approximately, to 105 RLU mL-1. 
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Figure 8 – Relationship between the bioluminescence signal and viable counts of overnight cultures of recombinant 
bioluminescent E. coli serially diluted in PBS. Viable counts are expressed in CFU mL-1 and bioluminescence in relative 
light units (RLU). Each value represents mean ± standard deviation of two independent experiments (---- E. coli 
suspension in the absence of PS, ―― E. coli suspension with 5.0 µM of Tri-Py+-Me-PF incubated in the dark). 
  
 
Two experiments of photodynamic inactivation were also done, in order to verify 
the correlation between the CFU and bioluminescence signal, in the presence of light and 
PS. E. coli cells from overnight cultures were photoinactivated with the meso-substitued 
tricationic porphyrin Tri-Py+-Me-PF resulting in a loss of viable counts (decrease of 7.9 log 
units) and simultaneously in a loss of bioluminescence signal to the limits of detection 
(decrease of 5.3 log units) (Figure 9). 
 
  
Figure 9 – Photodynamic inactivation assays determined by colony-forming units (A) and bioluminescence (B). 
Bioluminescent E. coli was treated with 5.0 µM of Tri-Py+-Me-PF during 270 min with artificial white light (4 mW cm-
2). Each value represents mean ± standard deviation of two independent experiments (-- Tri-Py+-Me-PF dark 
control, -- E. coli light control, -- Tri-Py+-Me-PF 5.0 µM). 
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EFFECT OF FREE RADICAL SCAVENGERS AND SINGLET OXYGEN QUENCHER ON BACTERIAL INACTIVATION 
The effect of sodium azide (A), L-cysteine (B) and D-mannitol (C) on the 
photoinactivation of bioluminescent E. coli by Tri-Py+-Me-PF (0.5 µM) is shown in Figure 
10. Using sodium azide as singlet oxygen quencher, a reduction of 0.8 log units on 
bioluminescence signal was obtained after 270 minutes of irradiation, comparatively with 
a reduction to the limits of detection of 5.9 log units under the same conditions with Tri-
Py+-Me-PF (0.5 µM) without scavenger. However, in the presence of the free radical 
scavengers L-cysteine and D-mannitol the decrease on bacterial bioluminescence was 
significantly higher, 5.8 and 5.4 log units, respectively (reduction of 6.1 logs with Tri-Py+-
Me-PF without scavenger).  
A 
 
B 
 
C 
 
Figure 10 - Effect of sodium azide (A), L-cysteine (B) and D-mannitol (C) at 100 mM on E. coli photoinactivation with 
Tri-Py+-Me-PF. Bioluminescent E. coli was treated with 0.5 µM of Tri-Py+-Me-PF during 270 min with artificial white 
light (4 mW cm-2). Each value represents mean ± standard deviation of two independent experiments (-- Tri-Py+-
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Me-PF dark control, -- Tri-Py+-Me-PF 0.5 µM, -- scavenger 100 mM, -- scavenger dark control, -- E. coli light 
control). 
 
The results of sodium azide (A), L-cysteine (B) and D-mannitol (C) on the 
photoinactivation of bioluminescent E. coli by Tetra-Py+-Me (5.0 µM) are represented in 
Figure 11. In the presence of sodium azide, a reduction of 1 log unit was obtained after 
270 min of irradiation comparatively with the control Tetra-Py+-Me (5.0 µM) that has a 
decrease of 4.9 log units. Reductions of 6.0 log units on bioluminescence signal were 
achieved with L-cysteine and D-mannitol (reduction of 6.2 logs on bioluminescence signal 
with Tetra-Py+-Me without scavenger). 
A
 
B
 
C 
 
Figure 11 - Effect of sodium azide (A), L-cysteine (B) and D-mannitol (C) at 100 mM on E. coli photoinactivation with 
Tetra-Py+-Me. Bioluminescent E. coli was treated with 5.0 µM of Tetra-Py+-Me during 270 min with artificial white 
light (4 mW cm-2). Each value represents mean ± standard deviation of two independent experiments (--Tetra-Py+-
Me dark control, -- Tetra-Py+-Me 5.0 µM, -- scavenger 100 mM, -- scavenger dark control, -- E. coli light 
control). 
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The effects of sodium azide (A), L-cysteine (B) and D-mannitol (C) on the 
photoinactivation of bioluminescent E. coli by Tri-SPy+-Me-PF (5.0 µM) are shown in 
Figure 12. The results obtained with this PS are quite different from those of Tri-Py+-Me-
PF and Tetra-Py+-Me. After 270 minutes of irradiation, a reduction of 0.2 log units was 
achieved in the presence of sodium azide (reduction of 3.5 log units with Tri-SPy+-Me-PF 
without sodium azide) comparatively with 3.2 log units obtained with D-mannitol 
(reduction of 3.9 log units with Tri-SPy+-Me-PF). However, using L-cysteine as free radical 
scavenger the results were unexpected. A reduction of 0.7 log unit was achieved 
comparatively with a reduction of 3.9 logs on bioluminescence signal with Tri-SPy+-Me-PF, 
after 270 minutes of irradiation. 
A 
 
B
 
C 
 
Figure 12 - Effect of sodium azide (A), L-cysteine (B) and D-mannitol (C) at 100 mM on E. coli photoinactivation with 
Tri-SPy+-Me-PF. Bioluminescent E. coli was treated with 5.0 µM of Tri-SPy+-Me-PF during 270 min with artificial white 
light (4 mW cm-2). Each value represents mean ± standard deviation of two independent experiments (-- Tri-SPy+-
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Me-PF dark control, -- Tri-SPy+-Me-PF 5.0 µM, -- scavenger 100 mM, -- scavenger dark control, -- E. coli light 
control). 
 
 
CONTROL SAMPLES 
The results suggest that the viability of the recombinant bioluminescent E. coli is 
not affected either by irradiation itself (E. coli light control) or by any of the PS tested in 
the dark (porphyrin dark control), the inhibitors tested in the dark (inhibitor dark control) 
and inhibitors exposed to light (inhibitor light control) (Figure 13).  
 
 
Figure 13 – Light controls of oxygen scavengers: sodium azide, L-cysteine and D-mannitol. Each value represents mean 
± standard deviation of two independent experiments (-- sodium azide light control, -- L-cysteine light control, -
- D-mannitol light control). 
 
SINGLET OXYGEN GENERATION AND PHOTOSTABILITY STUDIES 
Studies concerning the photostability of the PS were performed and the results 
are presented in Figure 14A. The results show that Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-
SPy+-Me-PF do not photobleach during 270 minutes of irradiation.  
The ability of these cationic porphyrins to generate singlet oxygen is represented 
in Figure 14B. The results indicate that the DPiBF photodegradation is highly enhanced in 
the presence of the PS. Under the same experimental conditions, the porphyrin Tri-Py+-
Me-PF seems to be more efficient than Tetra-Py+-Me which is considered a good singlet 
oxygen producer (Merchat et al., 1996b; Merchat et al., 1996a; Jemli et al., 2002). On the 
other hand, the porphyrin Tri-SPy+-Me-PF is the derivative that generates less singlet 
oxygen. 
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A 
 
B 
 
Figure 14 – Photostability of Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF after irradiation with white light at a 
fluence rate of 4 mW cm-2 (A) (-- Tri-Py+-Me-PF; -- Tetra-Py+-Me; -- Tri-SPy+-Me-PF). Photodecomposition of 
DPiBF by singlet oxygen generated by Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF after irradiation with white 
light filtered through a cut-off filter for wavelength < 550 nm (9 mW cm-2) (B) (-- Tri-Py+-Me-PF; -- Tetra-Py+-Me; -
- Tri-SPy+-Me-PF; -- DPiBF). 
 
 
Figure 15 shows the influence of L-cysteine on the generation of singlet oxygen by the 
porphyrins Tri-Py+-Me-PF (A), Tetra-Py+-Me (B) and Tri-SPy+-Me-PF (C). It can be observed 
reductions of 40% and 20% on the generation of singlet oxygen when the scavenger was 
added to the porphyrin derivatives Tri-Py+-Me-PF and Tetra-Py+-Me, respectively. In the 
case of Tri-SPy+-Me-PF, when L-cysteine was added to the PS, it was not observed any 
generation of singlet oxygen by this porphyrin. 
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C 
Tri-SPy+-Me-PF 
 
Figure 15 - Photodecomposition of DPiBF by singlet oxygen generated in the presence of L-cysteine by Tri-Py+-Me-PF 
(A), Tetra-Py+-Me (B) and Tri-SPy+-Me-PF (C) after irradiation with white light filtered through a cut-off filter for 
wavelength < 550 nm (9 mW cm-2) (--DPiBF; -- L-cysteine + PS; -- L-cysteine; -- PS). 
 
The influence of D-mannitol on the generation of singlet oxygen of the porphyrins 
Tri-Py+-Me-PF (A), Tetra-Py+-Me (B) and Tri-SPy+-Me-PF (C) is shown in Figure 16. It was 
observed that adding D-mannitol to the PS, the obtained data are equal from those 
obtained with the PS alone, where it was achieved a decay on absorbance of DPiBF of 
60%, 40% and 20% by Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF, respectively. 
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C  
Tri-SPy+-Me-PF 
 
Figure 16 - Photodecomposition of DPiBF by singlet oxygen generated in the presence of D-mannitol by Tri-Py+-Me-PF 
(A), Tetra-Py+-Me (B) and Tri-SPy+-Me-PF (C) after irradiation with white light filtered through a cut-off filter for 
wavelength < 550 nm (9 mW cm-2) (--DPiBF; -- D-mannitol + PS; -- D-mannitol; -- PS). 
 
DISCUSSION 
Antimicrobial photodynamic therapy represents a new promising approach to 
inactivate bacteria, fungi, protozoa and viruses (Wainwright, 1998; Bonnett, 2000; Alouini 
and Jemli, 2001; Wainwright, 2004; Lambrechts et al., 2005a; Alves et al., 2008; Costa et 
al., 2008; Oliveira et al., 2009). As the efficiency of microbial PI depends on the amount of 
singlet oxygen (type II mechanism) and/or of free radicals (type I mechanism) produced 
during the photodynamic process, it is important to know which of these ROS are 
generated in order to improve the design of the PS and to decide about the best 
conditions for microbial PI. The simplest approach for determining whether 1O2 or free 
radicals are involved in a PI reaction is to study the inhibitory effects of various 
scavengers of 1O2 and of free radicals (Girotti, 2001). 
Tri-Py+-Me-PF porphyrin was recently described as a promising PS for the 
inactivation of several types of MO (Carvalho et al., 2007; Alves et al., 2008; Costa et al., 
2008; Alves et al., 2009; Oliveira et al., 2009). While it was used a concentration of 5.0 µM 
for Tetra-Py+-Me and Tri-SPy+-Me-PF porphyrins, for Tri-Py+-Me-PF porphyrin it was used 
a lower concentration (0.5 µM) in order to observe an inhibitory effect of the PI process.  
The results of this study, as those obtained in other studies (Müller-Breitkreutz et 
al., 1995; Hadjur et al., 1998; Maisch et al., 2005; Maclean et al., 2008; Omar et al., 2008), 
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show clearly that singlet oxygen-mediated reactions (type II mechanism) represent the 
main pathway through which the PS exert their photodynamic action. However, although 
singlet oxygen plays the major role in the photodynamic process, free radicals-mediated 
reactions are produced simultaneously, contributing also to the bacteria PI, however, to a 
much smaller extent. 
The singlet oxygen quencher tested, sodium azide, led to an inhibition of the PI of 
the three porphyrins used (reductions of 5.1, 3.9, and 3.3 log units on the PI of Tri-Py+-
Me-PF at 0.5 µM, Tetra-Py+-Me at 5.0 µM and Tri-SPy+-Me-PF at 5.0 µM, respectively), 
and this reduction is proportional to the singlet oxygen generation by the PS. Tri-Py+-Me-
PF is the PS that generates the highest amount of 1O2 and it is the porphyrin that shows 
the highest reduction of PI in the presence of sodium azide. Tri-SPy+-Me-PF is the 
porphyrin that generates the smallest amount of 1O2 and is also the PS that shows the 
lowest reduction of PI in the presence of the scavenger. Moreover, the most effective PS 
to inactivate Gram-positive and Gram-negative bacteria at 5.0 µM is Tri-Py+-Me-PF, 
followed by Tetra-Py+-Me and Tri-SPy+-Me-PF (Alves et al. 2009; Alves et al., unpublished 
data) and the same pattern of variation is observed relatively to the 1O2 production. 
The free radical scavenger D-mannitol led to a small decrease on the PI of the 
three porphyrins (reductions of 0.7, 0.2, and 0.7 log units on the activity of Tri-Py+-Me-PF 
at 0.5 µM, Tetra-Py+-Me at 5.0 µM and Tri-SPy+-Me-PF at 5.0 µM, respectively). When L-
cysteine is used as free radical scavenger, the decrease on the PI of Tri-Py+-Me-PF and 
Tetra-Py+-Me is similar to that obtained with D-mannitol (reductions of 0.3 and 0.2 log 
units, respectively). However with Tri-SPy+-Me-PF the inhibition on the PI of the PS is 
higher (reduction of 3.2 log units), reaching reduction values only a little bit lower than 
those observed with the 1O2 quencher sodium azide. However, the reduction of PI of the 
PS by L-cysteine is not due to the inhibition of free radicals produced but due to a direct 
inhibition of the PS by L-cysteine. The antioxidant activity of cysteine is due to its 
sulfhydryl group, acting as the free radical scavenger, and so as the antioxidants, in 
biological and other systems (Taylor and Richardson, 1980). According to the chemical 
structure of Tri-SPy+-Me-PF, it is suspected that disulfide bridges take place between L-
cysteine and Tri-SPy+-Me-PF stopping the activity of the PS and, consequently, the 
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production of ROS. This can explain the fact that using L-cysteine as a free radical 
scavenger there is a reduction on the bioluminescence signal of E. coli as a result of the 
lost of the activity of Tri-SPy+-Me-PF. In fact, the production of 1O2 by the porphyrin Tri-
SPy+-Me-PF in the presence of L-cysteine decreases greatly. Although non-expected, L-
cysteine also affects the production of 1O2 by the other two porphyrins without sulfhydryl 
group. However, the production of singlet oxygen is not stopped by this scavenger as 
occurred with Tri-SPy+-Me-PF. Besides, these reductions on the generation of singlet 
oxygen by Tri-Py+-Me-PF and Tetra-Py+-Me porphyrins are not relevant to the results 
since the data obtained with these porphyrins do not exhibit the same result obtained 
with Tri-SPy+-Me-PF when the free radical scavenger L-cysteine was added to the beaker, 
even for Tri-Py+-Me-PF that was used ten time less concentrated that the other two PS. It 
was also tested the effect of D-mannitol on the generation of singlet oxygen and it was 
verified that this scavenger does not affect the production of 1O2 by all the PS tested. 
Porphyrins can undergo photobleaching when exposed to light and oxygen 
(MacRobert et al., 1989). The rate of photodegradation shown by a PS after exposure to 
light is an important parameter to assess, because a rapid photobleaching would cause a 
decrease on the concentration of the PS, thus impairing the efficiency of the treatment 
(Silva et al., 2005). It was observed that Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF 
do not photobleach during 270 minutes of irradiation. Such absence of photodegradation 
suggests that the concentration of the PS may be unaffected by light during the 
irradiation period required for the PI of bacteria. 
Photosensitized oxidation may change the type of pathways during the course of 
the reaction as the concentration of compounds and oxygen changes (Min and Boff, 
2002). For the conditions used in this work for the three porphyrins tested, it was not 
shown any changes on the type of mechanisms followed in the course of the 
photodynamic reaction, even for Tri-Py+-Me-PF for which the concentration used was ten 
times lower than those used for the other two PS. It is well documented that type I 
pathway mostly depends on the type and concentration of PS (Korycka-Dahl and 
Richardson, 1978). However, for the three PS used in this study, the type II pathway is 
clearly the most implicated in the bacterial oxidation and, consequently, the type and 
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concentration of PS do not affect the course of the reaction. As the type II reaction is 
mostly dependent on the solubility and concentration of oxygen (He et al., 1998; Song et 
al., 1999) and the solubility of the three porphyrins and the concentration of oxygen are 
similar during the laboratorial experiments for all PS, no difference is observed among 
them during the irradiation period. 
 As shown by Alves et al. (2008), the use of stable bioluminescent bacteria allows 
following the progress of the PI process with real-time results. The bacterial 
bioluminescent method is also a simple, fast, cost-effective and sensitive way to evaluate 
which mechanism is responsible for the bacterial inactivation during the photodynamic 
process (Alves et al., 2008). The relationship between viable counts and the 
bioluminescence signal is similar in absence and in presence of the PS showing that it is 
not toxic to the recombinant bioluminescent E. coli and does not affect the relationship 
between bacterial growth and bioluminescence (Alves et al., 2008). Furthermore, the 
results obtained in this study with the controls indicate that the viability of 
bioluminescent strain is not affected by the porphyrin after 270 minutes of incubation in 
the dark (porphyrin dark control) or by light irradiation nor by the inhibitors at the tested 
concentrations (inhibitor light and dark controls). The bioluminescent E. coli is only 
affected by irradiation in the presence of the sensitizer indicating that the decrease in 
bacterial viability is due to the PI process. 
 
CONCLUSION 
It can be concluded that singlet oxygen (type II mechanism) plays the most 
important role on the PI process of the tested bioluminescent E. coli by Tri-Py+-Me-PF, 
Tetra-Py+-Me and Tri-SPy+-Me-PF derivatives. The employment of scavengers to evaluate 
which pathway(s) is(are) involved in the photodynamic process is an adequate and simple 
approach. However, it has to be taken into account that scavengers must be chosen 
considering the chemical structure of the photosensitizer. 
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ANTIMICROBIAL PHOTODYNAMIC THERAPY: STUDY OF BACTERIAL RECOVERY VIABILITY 
AND POTENTIAL DEVELOPMENT OF RESISTANCE AFTER TREATMENT 
 
 
ABSTRACT 
Antimicrobial photodynamic therapy (aPDT) has emerged in the clinical field as a potential 
alternative technique to antibiotics drugs to treat microbial infections. At the moment, it is still 
not known any microbial viability recovery nor any resistance mechanism against it. In 
photodynamic therapy it is used a non-toxic photosensitizer that may be activated by low doses 
of visible light of an appropriate wavelength and generate reactive oxygen species (singlet oxygen 
and free radicals) which are toxic to target cells. In this work, we aim to test if bacteria can 
recover their metabolism after photodynamic inactivation and to study the possible development 
of resistance mechanisms after several treatments. The tricationic porphyrin Tri-Py+-Me-PF will be 
used as photosensitizer and the bioluminescent bacteria Vibrio fischeri and recombinant 
Escherichia coli as bacterial models. To determine the recovery of bacterial activity after 
treatment, 5.0 µM of Tri-Py+-Me-PF were added to individual bacterial suspensions and the 
samples were irradiated with white light (4 mW cm-2) during 270 minutes. After treatment, the 
samples were protected from light with aluminium foil and maintained at 25°C under stirring (100 
rpm). Aliquots of the samples were collected 24, 48, 72 and 168 hours after the photodynamic 
treatment and the bioluminescence signal was measured in a luminometer. To assess the 
development of resistance in bacterial cells after treatment, bacterial suspensions were exposed 
to white light for 25 minutes, with 5.0 μM of Tri-Py+-Me-PF and plated on appropriate media. 
After the first irradiation period, three surviving colonies were collected from the plate and each 
of them was suspended in PBS. The three bacterial suspensions were exposed to visible light using 
an identical irradiation protocol. This procedure was repeated for ten times for each bacterium. 
The obtained results suggest that aPDT using Tri-Py+-Me-PF represents a promising approach to 
efficiently destroy bacteria since after a single treatment these microorganisms do not recover 
their viability and after ten generations of partially photosensitized cells both bacteria do not 
develop resistance to the photodynamic process. 
 
Keywords Cationic porphyrins; antimicrobial photodynamic therapy; bacterial resistance; bacterial viability; 
bioluminescence; Vibrio fischeri; Escherichia coli 
 
INTRODUCTION 
The use of antibiotics to destroy selectively microorganisms (MO) represents one 
of the most revolutionary progresses made in scientific medicine, resulting in the 
treatment and sometimes complete eradication of earlier incurable diseases (Tunger et 
al., 2000; Jori and Brown, 2004). It might have been supposed that microbiologically-
based disease at the beginning of the twenty first century would have been reduced to a 
level that no longer had a serious impact on human health. However, bacteria have 
developed resistance mechanisms against antimicrobial drugs which were previously 
highly effective. Besides, bacteria replicate very rapidly and a mutation that helps a MO to 
survive in the presence of an antibiotic will quickly become predominant in the microbial 
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population (Hamblin and Hasan, 2004; Jori and Brown, 2004). Due to resistance to all ß-
lactam antibiotics, the glycopeptid antibiotic vancomycin was remained as last line of 
defense against Gram-positive bacteria. However, methicillin-resistant Staphylococcus 
aureus and vancomycin-resistant enterococci are resistant species that are causing much 
concern at present (Cunha, 1998). There is an urgent need for the development of novel, 
convenient, non-resistant and inexpensive measures for fighting microbial diseases (Malik 
et al., 1990; Wainwright, 1998; Jori and Brown, 2004). 
Antimicrobial photodynamic therapy (aPDT) represents a potential alternative 
methodology to inactivate microbial cells (Taylor et al., 2002; Winckler, 2007; Caminos et 
al., 2008) and has already showed to be effective in vitro against bacteria, fungi, viruses, 
and protozoa (Merchat et al., 1996b; Wainwright, 1998; Bonnett, 2000; Jemli et al., 2002; 
Wainwright, 2004; Alves et al., 2008; Costa et al., 2008; Alves et al., 2009; Oliveira et al., 
2009). The aPDT approach is based on the photodynamic therapy concept that comprises 
the action of three components: a photosensitizing agent (PS), light of an appropriate 
wavelength (artificial light or sunlight) and the presence of oxygen (Wainwright, 1998; 
Bonnett, 2000; Wainwright, 2000; Jori and Brown, 2004; Jori et al., 2006). Two oxidative 
mechanisms of photoinactivation (PI) are considered to be implicated in the inactivation 
of the target cells. The type I pathway involves electron/hydrogen atoms-transfer 
reactions from the PS triplet state with the participation of a substrate to produce radical 
ions while the type II pathway involves energy transfer the PS triplet state to molecular 
oxygen to produce excited-state singlet oxygen (1O2) (Wainwright, 1998; De Rosa and 
Bentley, 2000; Hamblin and Hasan, 2004; Donnelly et al., 2008; Calin and Parasca, 2009). 
Both of these processes lead to highly toxic reactive oxygen species (ROS) such as 1O2 and 
free radicals, able to irreversibly alter cells' vital components resulting in oxidative lethal 
damage (De Rosa and Crutchley, 2002; Ergaieg et al., 2008). The principal advantages of 
aPDT are the MO non-target specificity, the few side effects, the prevention of the 
regrowth of the MO after the treatment and the lack of development of resistance 
mechanisms due to the mode of action and type of biochemical targets (multi-target 
process) (Jori et al., 2006; Winckler, 2007). 
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The photodynamic activity can mainly produce changes in the cytoplasmatic 
membrane and damages the DNA (Hamblin and Hasan, 2004). The damages to the 
cytoplasmatic membrane can involve leakage of cellular contents or inactivation of 
membrane transport systems and enzymes (Li et al., 1997; Mettath et al., 1999). Some 
damages produced in the DNA chain can be repaired by the action of DNA repairing 
systems (Imray and MacPhee, 1973). However, it was concluded that although DNA 
damage occurs it cannot be the main cause of bacterial cell photodynamic inactivation 
(Hamblin and Hasan, 2004; Durantini, 2006), since Deinococcus radiodurans, which is 
known to have a very efficient DNA repair mechanism, is easily killed by aPDT (Schafer et 
al., 1998).  
Although various studies investigated the possible recovery of bacterial infections 
in animal models (in vivo) (Orenstein et al., 1997; Gad et al., 2004b; Lambrechts et al., 
2005b), there are not published studies that tested, in vitro, the possible viability recovery 
after an aPDT treatment. Moreover, despite various authors refer that resistance to aPDT 
is unlikely because the mechanism of killing is non-specific, with ROS causing damage of 
diverse bacterial structures (Ito and Kobayashi, 1977; Bagchi and Sreeradha, 1989; 
Ehrenberg et al., 1993; Bhatti et al., 1998; Carré et al., 1999; Maisch et al., 2004; Omar et 
al., 2008; Cassidy et al., 2009), only some studies were made to determine if bacterial 
resistance occurs after several treatments of aPDT. Cell wall structures and membranes 
are the main target of photodynamic therapy drugs, and for this reason the drugs do not 
necessarily need to enter the cell. Specific and proper adhesion to these structures 
suffices for light-activated destruction of the target cell. Thus target cells have no chance 
to develop resistance by stopping uptake, increasing metabolic detoxification or 
increasing export of the drug (Winckler, 2007). The investigations in aPDT are more 
focused to the identification of new PS that kill rapidly and efficiently the MO at low costs 
and to determine the way of inactivation of those PS. However, and regarding the 
emergence of bacterial resistance to antibiotics, it is important to control the process of 
PI in terms of resistance development. Lauro et al. (2002) investigated the selection of 
resistant bacterial strains in Peptostreptococcus micros and Actinkobacillus 
actinomycetemcomitans after repeated photosensitization of surviving cells with the 
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porchycene-polylysine conjugates 2,7,12,17-tetrakis(2-methoxyethyl)-9-
glutaramidoporphycene (GlamTMPn) and 2,7,12,17-tetrakis(2-methoxyethyl)-9-p-
carboxybenzyloxyporphycene (BOHTMPn). The results obtained by this group showed 
that the photosensitization of P. micros and A. actinomycetemcomitans by both PS 
induced no appreciable development of resistance in partially inactivated bacterial cells. 
The efficiency of photokilling underwent no change in ten subsequent irradiation 
sessions, even though cells which were damaged in a previous treatment were cultivated 
and re-exposed to porphyene and light (Lauro et al., 2002). Pedigo et al. (2009) 
determined the possible development of bacterial resistance to aPDT after several 
treatments in antibiotic sensitive (MSSA) and resistant strains (MRSA) of S. aureus and 
antibiotic sensitive Escherichia coli. Bacteria were exposed to repetitive aPDT treatments 
using methylene blue as PS and 670 nm illumination from a non-thermal diode laser. The 
parameters were adjusted such that kills were lowest than 100% so that surviving 
colonies could be employed for succeeding exposures. No significant difference in killing 
of E. coli was observed through eleven repeated exposures. Similar results were seen 
using MSSA and MRSA, for which kill rate did not significantly differ from over twenty five 
repeated exposures (Pedigo et al., 2009). Jori et al. (unpublished data) determined that 
up to five consecutive generations of extensively  photoinactivated MRSA (ca. 90%) show 
essentially identical degrees of sensitivity to phthalocyanine photosensitization (Jori and 
Coppellotti, 2007). Although the known studies indicate that bacterial resistance to aPDT 
is unlikely, it is an important parameter to be evaluated when a new PS is considered for 
aPDT. 
To monitor the possible development of bacterial resistance to aPDT, faster 
methods are needed as alternative to laborious conventional methods of diluting, plating, 
overnight incubation and time-consuming counting of colony-forming units (CFU) (Simon 
et al., 2001; Vesterlund et al., 2004; Demidova and Hamblin, 2005; Alves et al., 2008). The 
employment of bacterial bioluminescence method is considered to be a rapid, sensitive 
and cost-effective choice (Francis et al., 2001; Hamblin et al., 2002; Vesterlund et al., 
2004; Alves et al., 2008) to monitor the possible development of resistance after several 
treatments to aPDT, and can be measured directly, continuously and non-destructively in 
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high-throughput screening or continuous-culture models (Beard et al., 2002). A strong 
correlation between bioluminescence and viable counts was demonstrated in 
experimental systems (Marincs, 2000; Rocchetta et al., 2001; Alves et al., 2008), where 
the light output reflects the actual metabolic rate. 
 The aim of this study is to determine if bacterial cells can recover their activity 
after photodynamic treatment and to investigate the possible development of resistance 
to aPDT after various treatments. To achieve these goals, two bioluminescent Gram-
negative bacteria were tested (Vibrio fischeri and recombinant Escherichia coli), using a 
meso-substituted tricationic porphyrin derivative as PS and the bacterial bioluminescent 
method to evaluate bacterial activity. 
 
MATERIALS AND METHODS 
 
PHOTOSENSITIZER 
In this work it was used the tricationic porphyrin derivative 5,10,15-tris(1-
methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri-iodide (Tri-Py+-Me-PF), that 
was prepared in two steps according to the literature (Tomé et al., 2004). In the first step, 
the neutral porphyrin was synthesized by crossed Rothemund reactions using pyrrole and 
the adequate benzaldheydes at reflux in acetic acid and nitrobenzene. The resulting 
porphyrin was separated by column chromatography (silica) and pyridyl groups 
quaternized by reaction with methyl iodide. The porphyrin was purified by crystallization 
from chloroform/methanol/petroleum ether and their purities were confirmed by thin 
layer chromatography and by 1H NMR spectroscopy. A stock solution of 500 µM of the 
porphyrin (dissolved in DMSO) was prepared and then maintained at 4°C. 
 
 
Figure 17 – Structure of 5,10,15-tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri-iodide. 
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BACTERIAL STRAINS AND GROWTH CONDITIONS  
 The bacterial strains used in this work were a recombinant bioluminescent strain 
of E. coli prepared in a previous work (Alves et al., 2008) and the bioluminescent marine 
bacterium Vibrio fischeri ATCC 49387. Both E. coli and V. fischeri were stored at -80°C in 
10% of glycerol. 
Before each assay, an aliquot of V. fischeri was aseptically plated on tryptic soy 
agar (TSA, Merck) complemented with 3% of NaCl (because of the osmotic pressure 
required to natural light emission to occur) and grown for one day at 25°C. Next, one 
colony was aseptically inoculated on Luria-Bertani broth with saline medium (LBS; 10 g of 
tryptone, 5 g of yeast extract and 30 g NaCl per liter; pH 7.5) (Geske et al., 2007) and 
grown for one day at 25°C under stirring (100 rpm). Afterwards, an aliquot of this culture 
was subcultured in 30 mL of LBS and grown overnight at 25°C, 100 rpm stirring. The same 
procedure was carried out with E. coli, however, this bacterium contains two plasmids 
that confer resistance to two antibiotics: ampicilin (Amp) and chloramphenicol (Cm). 
Consequently, E. coli was aseptically plated on TSA with 100 mg mL-1 of Amp and 25 mg 
mL-1 of Cm and grown for one day at 37°C. Next, one colony was aseptically inoculated on 
tryptic soy broth (TSB, Merck) with both antibiotics and grown for one day at 25°C under 
stirring (100 rpm). Then, an aliquot of this culture was subcultured in 30 mL of TSB with 
Amp and Cm and grown overnight at 25°C, 100 rpm stirring. 
 
BIOLUMINESCENCE VERSUS CFU 
To evaluate the correlation between the CFU and the bioluminescence signal of V. 
fischeri, two assays were carried out in dark conditions, with and without porphyrin (Tri-
Py+-Me-PF). Two suspensions were prepared from an overnight culture of V. fischeri, 
diluting the culture (1:10) in fresh phosphate buffered saline with 3% of NaCl (PBS with 
3% of NaCl: 30 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4 and 0.24 g KH2PO4 per liter; pH 7.4) to a 
final concentration of 107 CFU mL-1. In one of these bacterial suspensions, an appropriate 
volume of porphyrin was added to achieve a final concentration of 5.0 µM, followed by a 
dark incubation during 4h at 25-28°C under stirring. Next, both suspensions were serially 
diluted (10-1 - 10-7) in PBS with 3% of NaCl. The non-diluted (100) and the diluted aliquots 
were plated in TSA with 3% of NaCl (100 µL) and, simultaneously, were read on a 
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luminometer (500 µL) (TD-20/20 Luminometer, Turner Designs, Inc., USA) to determine 
the bioluminescence signal. 
The correlation between the CFU and the bioluminescence signal of E. coli was 
determined in a previous study (chapter 2 of this thesis). The procedure was the same 
done with V. fischeri, however, the suspensions were prepared in PBS without the 
addition of NaCl (PBS; 8 g NaCl, 0,2 g KCl, 1,44 g Na2HPO4 and 0,24 g KH2PO4 per liter; pH 
7.4) and pour plated in TSA without NaCl. 
Both experiments were done in duplicate and the results were averaged. 
 
aPDT RECOVERY STUDY 
A photodynamic inactivation assay was done in order to determine if bacterial 
cells can recover their metabolism after an effective treatment. For this purpose, cultures 
of V. fischeri and E. coli were grown overnight and diluted in PBS, supplemented with 3% 
of NaCl in the case of V. fischeri, to a final concentration of 107 CFU mL-1. These bacterial 
suspensions were equally distributed in 600 mL sterilized and acid-washed beakers. 
Afterwards, the appropriate volume of Tri-Py+-Me-PF was added to achieve a final 
concentration of 5.0 µM (total volume in the beakers was 15 mL). Light and dark controls 
were included in all experiments. The samples were protected from light with aluminum 
foil and incubated for 10 min under 100 rpm stirring (25-28°C) to promote the porphyrin 
binding to bacterial cells. Then, the mixtures were exposed to white light with a fluence 
rate of 4 mW cm-2 for 270 minutes (corresponding to a light fluence of 64.8 J cm-2) under 
100 rpm (25-28°C). Aliquots of treated and control samples were collected at time 0 and 
after 15, 30, 45, 60, 90, 180 and 270 min of light exposure and the bioluminescence signal 
was measured in the luminometer. After 270 min of irradiation, when all bacteria were 
inactivated to the detection limit of the method, the samples were protected from light 
with aluminum foil and maintained under stirring at 25-28°C. Aliquots of treated and 
control samples were collected after 24, 48, 72 and 168 hours post-treatment and the 
bioluminescence signal was measured in the luminometer. 
Both experiments were done in duplicate and the results were averaged. 
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aPDT RESISTANCE STUDY 
 In order to assess the possible development of resistance in bacterial cells after 
photosensitized inactivation, cultures of V. fischeri and E. coli grown overnight were 
centrifugated at 10 000 g during 15 minutes to remove dead cells and residues of culture 
medium, and the cells thus obtained were ressuspended in PBS, supplemented with 3% of 
NaCl in the case of V. fischeri. Bacterial suspensions (107 CFU mL-1) were equally 
distributed in 600 mL sterilized and acid-washed beakers and the suitable volume of Tri-
Py+-Me-PF was added to achieve a final concentration of 5.0 µM (total volume was 10 mL 
per beaker). The samples were protected from the light with aluminum foil and incubated 
for 10 min under 100 rpm stirring (25°C) to promote the porphyrin binding to bacterial 
cells. Afterwards, the mixtures were exposed to white light with a fluence rate of 4 mW 
cm-2 (under stirring at 25-28°C) to reach less than 100% of bacterial PI, around 1 log unit 
of surviving bacteria (25 minutes for both bacteria). At the end of each treatment, an 
aliquot of both samples was plated on TSA and the plates were incubated at 25°C in the 
case of V. fischeri and at 37°C for E. coli. Three colonies surviving after the first irradiation 
period were collected from the respective plate and each one was centrifugated at 10 000 
g (15 minutes), ressuspended in PBS and inoculated on the suitable liquid medium. 
Subsequently, the bacterial suspensions were incubated in the dark whit the PS and 
exposed to visible light using an identical irradiation protocol that was repeated for ten 
times for each bacterium. Before each assay, the optical densities of cultures of V. fischeri 
and E. coli were controlled and monitored to 0.5 and 1.3 (660 nm), approximately. The PI 
efficiency was expressed as log N0/N, where N0 and N represent the bioluminescence 
signal before and after the irradiation, respectively (Lauro et al., 2002). 
 
IRRADIATION CONDITIONS 
The studies were carried out by exposing the samples to white light (PAR 
radiation, 13 lamps OSRAM 21 of 18 W each one, 380–700 nm) with a fluence rate of 4 
mW cm-2 (measured with a radiometer LI-COR Model LI-250). As V. fischeri emits light at 
temperatures below 30°C (Scheerer et al., 2006), the samples were placed on a tray with 
water in order to maintain the samples at a constant temperature (25-28°C). 
 
CHAPTER 3 - ANTIMICROBIAL PHOTODYNAMIC THERAPY: STUDY OF BACTERIAL VIABILITY RECOVERY AND 
POTENTIAL DEVELOPMENT OF RESISTANCE AFTER TREATMENT 
63 
 
RESULTS 
BIOLUMINESCENCE VERSUS CFU 
It was observed (Figure 18) a linear correlation between viable counts and the 
bioluminescence signal of overnight cultures of the bioluminescent marine bacterium V. 
fischeri and of the recombinant bioluminescent E. coli. These correlations are similar in 
the presence and in the absence of Tri-Py+-Me-PF. 
 
A: Vibrio fischeri 
 
B: Escherichia coli 
 
Figure 18 - Relationship between the bioluminescence signal and viable counts of overnight cultures of 
bioluminescent marine bacterium Vibrio fischeri serially diluted in PBS with 3% of NaCl (A) and recombinant 
bioluminescent Escherichia coli serially diluted in PBS (chapter 2 of this thesis) (B) . Viable counts are expressed in 
CFU mL-1 and bioluminescence in relative light units (RLU). Each value represents mean ± standard deviation of two 
independent experiments (---- bacterial suspension in the absence of PS, ―― bacterial suspension with 5.0 µM 
of Tri-Py+-Me-PF incubated in the dark). 
 
 
aPDT RECOVERY STUDY 
 The ability of V. fischeri and E. coli cells to recover their metabolic capacities after 
a photodynamic treatment with 5.0 µM of Tri-Py+-Me-PF is represented in Figure 19 and 
Figure 20, respectively. After 270 minutes of irradiation, it was obtained a reduction of 
5.1 log units on the bioluminescence signal of V. fischeri and 6.4 log units for 
bioluminescent E. coli. Moreover, light and dark controls results show that the viability of 
these bacteria was neither affected by irradiation itself nor by the PS in dark conditions 
(Figures 19A and 20A). This indicates that the reductions obtained on cell viability after 
irradiation of the treated samples are due to the photosensitizing effect of the porphyrin.  
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 After one week of incubation in dark conditions (Figures 19B and 20B), it was 
observed that the bioluminescence signal of treated samples of V. fischeri and E. coli was 
the same during all period of incubation ( ≈ log -1.5 RLU for both V. fischeri and E. coli 
cells). It was also observed a decrease on the bioluminescence signal of light and dark 
controls of these bacteria.  
 
A 
 
B 
 
Figure 19 – Logaritmic reduction of V. fischeri treated with porphyrin Tri-Py+-Me-PF at 5.0 µM after 15, 30, 45, 60, 90, 
180 and 270 minutes of irradiation at 4 mW cm-2 (A). Bioluminescence signal of V. fischeri after 24, 48, 72 and 168 
hours of the photodynamic treatment (B). Each value represents mean ± standard deviation of two independent 
experiments (-- Tri-Py+-Me-PF dark control, -- V. fischeri light control, -- Tri-Py+-Me-PF 5.0 µM). 
 
A 
 
B 
 
Figure 20 – Logaritmic reduction of E. coli treated with porphyrin Tri-Py+-Me-PF at 5.0 µM after 15, 30, 45, 60, 90, 180 and 
270 minutes of irradiation at 4 mW cm-2 (A). Bioluminescence signal of E. coli after 24, 48, 72 and 168 hours of the 
photodynamic treatment (B).  Each value represents mean ± standard deviation of two independent experiments (-- Tri-
Py+-Me-PF dark control, -- E. coli light control, -- Tri-Py+-Me-PF 5.0 µM). 
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aPDT RESISTANCE STUDY 
 The repeated treatments of aPDT to determine the possible development of 
resistance to Tri-Py+-Me-PF porphyrin in partially inactivated V. fischeri and E. coli cells are 
represented in Figure 21A and 21B, respectively. It was observed that the efficiency of PI 
underwent no reduction in ten subsequent irradiations to destroy 99.99% of V. fischeri 
and E. coli cells. 
 
A 
 
B 
 
Figure 21 – Photodynamic inactivation efficiency of ten consecutive generations of a) V. fischeri and b) E. coli by 5.0 µM of 
Tri-Py+-Me-PF after 25 minutes of irradiation at 4 mW cm-2. N0 and N represent, respectively, the bioluminescence signal 
before and after the irradiation (Lauro et al., 2002). Each value represents mean ± standard deviation of three independent 
experiments. 
 
  
DISCUSSION 
 Microorganisms have adopted a large variety of mechanisms to increase their 
resistance to antimicrobial drugs. These mechanisms comprise a thickening of their outer 
wall, encoding of new proteins which prevent the penetration of drugs, and onset of 
mutants deficient in those porin channels allowing the influx of externally added 
chemicals (Harder et al., 1981; Roland et al., 1994; Boyle-Vavra et al., 2001). The 
emergence of antibiotic resistance by pathogenic MO has led to the search of efficient 
alternative methods for which mechanisms of resistance must not occur (Cassell and 
Mekalanos, 2001; Hamblin and Hasan, 2004). The aPDT represents a potential approach 
to inactivate pathogenic MO (Taylor et al., 2002; Caminos et al., 2008) and has already 
showed to be efficient against bacteria, yeasts, viruses, and protozoa (Merchat et al., 
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
5
1 2 3 4 5 6 7 8 9 10
Ph
ot
od
yn
am
ic
 in
ac
tiv
at
io
n 
ef
fic
ie
nc
y 
(L
og
 N
0/
N
)
Photodynamic treatments
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
5
1 2 3 4 5 6 7 8 9 10
Ph
ot
od
yn
am
ic
 in
ac
tiv
at
io
n 
ef
fic
ie
nc
y 
(L
og
 N
0/
N
)
Photodynamic treatments
 66 
 
1996b; Wainwright, 1998; Bonnett, 2000; Jemli et al., 2002; Wainwright, 2004; Alves et 
al., 2008; Costa et al., 2008; Alves et al., 2009; Oliveira et al., 2009). The main advantages 
of aPDT are the MO non-target specificity, the few side effects, the prevention of the 
regrowth of the MO after treatment and the potential lack of development of resistance 
mechanisms due to the mode of action and type of biochemical targets (multi-target 
process) (Jori et al., 2006; Winckler, 2007). In fact, as the main target of aPDT are cell wall 
structures and membranes, the PS do not need to enter in the cell, having no chance to 
develop resistance by stopping uptake, increasing export of the PS or increasing 
metabolic detoxification (Winckler, 2007).  
The results of this study shown that bacteria do not recover their metabolic 
capacities after 270 minutes of irradiation at 4 mW cm-2 using the Tri-Py+-Me-PF 
porphyrin. It was observed that when the samples are maintained during one week, in 
dark conditions, after the photodynamic treatments, the bioluminescence signal of both 
tested bacteria remains the same during all period of incubation ( ≈ log -1.5 RLU for both 
V. fischeri and E. coli cells). Dark and light controls showed a decrease on the 
bioluminescence signal, maybe as a result of the accumulation of toxic products resulting 
from metabolism and also maybe due to the lack of nutrients. These results are in 
agreement with the data obtained by Costa et al. (unpublished data) that observed that 
after a treatment with Tri-Py+-Me-PF porphyrin, it was not verified any recovery of T4-like 
bacteriophages following one week of incubation in dark conditions (Costa et al., 
unpublished data). 
It was also observed that the results obtained in this study corroborate the 
literature (Lauro et al., 2002; Jori and Coppellotti, 2007; Pedigo et al., 2009) in relation to 
the potential lack of microbial development of resistance mechanisms after the 
photodynamic process. It was demonstrated that bacterial resistance do not occur after 
ten repeated photosensitization processes using the bioluminescent marine bacterium V. 
fischeri and the bioluminescent recombinant E. coli. In fact, it was not observed any 
considerable reduction in the efficiency of photosensitization of V. fischeri and E. coli 
after repetitive photosensitization sessions of 25 minutes with 5.0 µM of Tri-Py+-Me-PF. If 
bacterial resistance occurred, it was expected that the time of irradiation increased from 
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each treatment to reach the 99.99% of photosensitized cells. Various authors affirmed 
that stationary phase cultures show a certain degree of resistance to the PS (Nitzan et al., 
1989; Bhatti et al., 1998). Others authors refer, however, that bacteria susceptibility to PS 
are independent from the growth phase (Gad et al., 2004a; Banfi et al., 2006). In this 
study, the cultures were used at the same growth phase (stationary growth phase) for all 
assays. As the bacterial colony has been aseptically removed from the plate and 
ressuspended in PBS, the cellular density obtained after the colony ressuspension could 
be different. To avoid differences in the efficiency of PI due to different bacterial density, 
this parameter was controlled in all the experiments by measuring the optical density of 
the bacteria suspension before each assay. 
It can be concluded that the promising photosensitizer Tri-Py+-Me-PF is able to 
destroy efficiently Gram-negative bacteria, after the photodynamic treatment, without 
the recovery of bacterial viability. It was also confirmed that the bacteria photosensitized 
by this photosensitizer do not develop resistance mechanisms against the photodynamic 
process. 
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Photosensitized oxidations can take place by two mechanisms known as type I and 
type II mechanisms. The type I pathway involves the initial interaction between the 
excited PS and the substrate by hydrogen-atom or electron transfer resulting in the 
production of free radicals. The type II mechanism takes place between molecular oxygen 
and the excited PS to produce singlet oxygen. All of these ROS formed in both pathways 
are able to irreversibly alter the cells' vital components resulting in oxidative lethal 
damage of the target cell (Wainwright, 1998; De Rosa and Crutchley, 2002; Hamblin and 
Hasan, 2004). It is important to know which ROS species are generated in order to 
improve the design of the PS and to decide about the best conditions for microbial 
photoinactivation. Although there are some studies that investigate which 1O2 or free 
radicals pathways are involved in the photoinactivation reaction, only few studies were 
done using MO, namely bacterial cells, and scavengers. Typical type I reactions at the 
bacterial cytoplasmatic membrane include the abstraction of allylic hydrogens from 
unsatured molecules such as phospholipids. The radical species thus formed may undergo 
reaction with oxygen to yield the lipid hydroperoxide leading to loss of fluidity and 
increased permeability (Korytowski et al., 1992; Wainwright, 1998). Singlet oxygen also 
reacts with biomolecules involved in the maintenance and structure of the cell 
wall/membrane such as phospholipids, peptides and sterols (Wainwright, 1998). Nucleic 
acids are known to react mainly through guanosine residues (Foote, 1990). Some 
damages produced in the DNA chain can be repaired by the action of DNA repairing 
systems (Imray and MacPhee, 1973). However, some authors concluded that although 
DNA damage occurs, it may not be the main cause of bacterial cell death (Hamblin and 
Hasan, 2004). As the main targets of ROS are cell wall structures and membranes, the PS 
does not necessarily need to enter the cell to cause cell death. A specific and a proper 
adhesion of the PS to these structures is sufficient for the light-activated destruction of 
the target cell. Consequently, target cells have no chance to develop resistance by 
stopping uptake, increasing metabolic detoxification or increasing the export of the PS 
(Winckler, 2007). 
According to the results obtained in this work, singlet oxygen-mediated reaction 
(type II mechanism) plays the most important role in the process of photoinactivation of 
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the strain of E. coli. Despite type II mechanism is the predominant reaction in the 
photodynamic inactivation, free radicals-mediated reactions are also produced 
simultaneously, contributing to the bacterial photoinactivation but to a much smaller 
extent. These data are in agreement with the literature where type II photoprocess is 
generally accepted as the major pathway in photooxidative microbial cell damage 
(Wainwright, 1998; Maclean et al., 2008; Omar et al., 2008) and that type I mechanism 
can also contribute in a minor way to the photodynamic inactivation (Nitzan et al., 1989; 
Müller-Breitkreutz et al., 1995; Abe et al., 1997; Wong et al., 2005; Ergaieg et al., 2008). 
Ergaieg et al (2008) studied the mechanism involved in the phototoxicity of meso-tetra 
(N-methyl-4-pyridyl) porphyrin tetra-tosylate (TMPyP) on E. hirae and E. coli using specific 
scavengers and quenchers of ROS. The group verified that using the singlet oxygen 
quenchers sodium azide, histidine and β-carotene, reductions on the photoinactivation 
activity of E. hirae and E. coli were obtained. Furthermore, using the free radical 
scavengers superoxide dismutase, catalase and DMSO they also achieved an decrease on 
the activity of TMPyP concluding that both type I and type II reactions play important 
roles on the process of PI of TMPyP (Ergaieg et al., 2008). The mechanism of S. aureus 
inactivation by deuteroporphyrin (DP) was investigated by Nitzan et al. The light-activated 
DP (10 µM mL-1) reduced the viability of the culture to less than 1%, while the singlet 
oxygen quenchers methionine, Trp, and 1,4-diazabicyclo-2,2,2-octane (DBCO) used as 
provided approximately 60% protection. Propylgallate (free radical scavenger) also 
conferred 60% of protection. The presence of a singlet oxygen quencher and 
propylgallate provided almost a complete protection from the photoinactivation (96%), 
indicating that S. aureus photoinactivation by DP is mediated by both singlet oxygen and 
hydroxyl free radicals (Nitzan et al., 1989). 
In this work, when sodium azide was used at 100 mM, reductions on the PI of the 
porphyrins Tri-Py+-Me-PF, Tetra-Py+-Me and Tri-SPy+-Me-PF were obtained after 270 
minutes of irradiation at 4 mW cm-2. Porphyrin Tri-Py+-Me-PF (0.5 µM) was the most 
effective PS (reduction of 5.1 log units for Tri-Py+-Me-PF and reductions of 3.9 and 3.3 log 
units for Tetra-Py+-Me 5.0 µM and Tri-SPy+-Me-PF 5.0 µM, respectively). The quenching of 
1O2 by sodium azide is probably due to a charge transfer process in which molecular 
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oxygen is released after the reaction and, consequently, no oxygen is consumed (Telfer et 
al., 1994). Moreover, theses reductions are proportional to the 1O2 generation by the PS, 
Tri-Py+-Me-PF is the PS that generates the highest amount of the 1O2 and Tri-SPy+-Me-PF 
is the porphyrin that generates the smallest amount of 1O2.  
When the free radical scavenger D-mannitol at 100 mM was used, it was observed 
a small reduction on the PI of all of the PS tested. Reductions of 0.7, 0.2 and 0.7 log units 
were obtained on the PI of Tri-Py+-Me-PF (0.5 µM), Tetra-Py+-Me (5.0 µM) and Tri-SPy+-
Me-PF (5.0 µM), respectively, after 270 minutes of irradiation at 4 mW cm-2. When L-
cysteine was used as free radical scavenger, the obtained results were similar from those 
obtained with D-mannitol for the cationic porphyrins Tri-Py+-Me-PF and Tetra-Py+-Me. 
Reductions of 0.3 and 0.2 log units on the PI of Tri-Py+-Me-PF and Tetra-Py+-Me were 
achieved after 270 minutes of irradiation. However, the results obtained with the 
tricationic porphyrin Tri-SPy+-Me-PF (5.0 µM) were unexpected and different from those 
obtained with D-mannitol. At 100 mM of L-cysteine, a high reduction on the PI of the PS 
was obtained (reduction of 3.2 log units on the activity of Tri-SPy+-Me-PF), reaching 
similar values than those observed with the 1O2 quencher sodium azide. Taylor and 
Richardson (1980) affirm that the antioxidant activity of cysteine is due to its sulfhydryl 
group in biological and other systems (Taylor and Richardson, 1980). According to the 
chemical structure of Tri-SPy+-Me-PF, it can be supposed that disulfide bridges take place 
between L-cysteine and Tri-SPy+-Me-PF stopping the activity of the PS and, consequently, 
the production of ROS. Singlet oxygen generation studies were made in order to 
understand what happens when L-cysteine is in contact with the PS. The obtained results 
indicate that the production of 1O2 by the Tri-SPy+-Me-PF porphyrin in the presence of L-
cysteine decreases completely, stopping the production of 1O2. These data can explain the 
fact that when L-cysteine is used, a high reduction on the activity of Tri-SPy+-Me-PF is 
obtained after 270 minutes of irradiation, as a result of a direct inactivation of the PS by L-
cysteine. However not expected, this scavenger also affects the production of 1O2 by the 
other two porphyrins without sulfhydryl group. But the production of 1O2 is not totally 
stopped by this scavenger as occurred with Tri-SPy+-Me-PF. Moreover, these reductions 
on the generation of 1O2 by Tri-Py+-Me-PF and Tetra-Py+-Me porphyrins are not relevant 
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on the study of mechanisms since the data obtained with these PS are different from 
those obtained with Tri-SPy+-Me-PF, even for Tri-Py+-Me-PF that was used in 
concentration ten times lower than the other two PS. The effect of D-mannitol on the 
generation of 1O2 was also tested and it was verified that this scavenger does not affect 
the production of 1O2 by all the PS tested. Although the employment of scavengers to 
evaluate which of the two pathways is involved in the photodynamic process is an 
adequate and simple approach, these results demonstrate that it is important to have 
into account that the scavengers must be chosen having in consideration the chemical 
structure of the photosensitizer.  
Min and Boff (2002) affirm that a photosensitized oxidation may change the types 
of pathway during the course of the reaction due to changes in the concentration of 
compounds and oxygen changes (Min and Boff, 2002). In our study, it was not detected 
any change for the three porphyrins tested on the type of mechanisms followed in the 
course of the photodynamic reaction, even for Tri-Py+-Me-PF. This porphyrin inactivates 
efficiently and rapidly Gram (+) and Gram (-) bacteria, sewage bacteriophages and 
bacterial endospores (Alves et al., 2008; Costa et al., 2008; Alves et al., 2009; Oliveira et 
al., 2009). For this reason, it was necessary to test the mechanism of this PS using a lower 
concentration comparatively to the other two PS (Costa et al., 2008; Alves et al. 2009; 
Alves et al. 2009 and unpublish data; Oliveira et al., 2009).  
According to Korycka-Dahl and Richardson (1978), the rate of the type I pathway is 
mainly dependent on the type and concentration of the PS, while the rate of type II 
pathway is mostly dependent on the solubility and concentration of oxygen (Korycka-Dahl 
and Richardson, 1978). Maclean et al. (2008) and Feuerstein et al. (2005) demonstrated 
that oxygen reduction has a negative effect on the photodynamic inactivation process, 
with the addition of reactive oxygen scavengers significantly reducing the efficacy of the 
visible light treatment. This was assumed to be due to the failure of the scavengers to 
efficiently scavenge the fast-binding of the highly reactive 1O2 as well as their partially 
ineffective access to the ROS produced within the cells (Feuerstein et al., 2005; Maclean 
et al., 2008). In this work and for the three cationic PS tested, the type II mechanism is 
clearly the main pathway implicated in the bacterial oxidation and, consequently, the 
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type and concentration of PS did not affect the way of the reaction. Furthermore, the 
solubility of the three PS and the concentration of oxygen were similar during the 
laboratorial experiments. 
The results obtained with all controls used for the evaluation of the mechanism of 
photoinactivation showed that the viability of the bioluminescent strain is not affected by 
the porphyrins after 270 min of incubation in the dark (porphyrin dark control) or by light 
irradiation nor by the inhibitors at the tested concentrations (inhibitor light and dark 
controls). The bioluminescent E. coli was only affected by the irradiation in the presence 
of the PS indicating that the decrease in bacterial viability is due to the photoinactivation 
process. 
The major advantages of aPDT are the high target specificity and the prevention of 
the recovery of microorganisms's viability after the aPDT treatment and the potential lack 
of development of resistance mechanisms due to the mode of action and the type of 
biochemical targets (multi-target process) (Jori et al., 2006; Winckler, 2007). The main 
target of aPDT are cell wall structures and membranes and, for these reasons, the PS do 
no need to enter in the cell and a specific and proper adhesion to these structures suffices 
for the light-activated destruction of target cell, with no chance to develop resistance by 
stopping uptake, increasing export of the PS or increasing metabolic detoxification 
(Winckler, 2007).  
The data obtained in this study demonstrate that bacterial cells do not recover 
their activity after 270 minutes of irradiation (4 mW cm-2) using the Tri-Py+-Me-PF 
porphyrin derivative. The bioluminescence signal of both tested bacteria, after the 
photodynamic treatments, remains the same during all period of incubation (one week in 
dark conditions), exhibiting very low signals of bioluminescence during this period (≈ log -
1.5 RLU for both V. fischeri and E. coli cells). Light and dark controls register a decline on 
the bioluminescence signal, probably due to the accumulation of toxic products resulting 
from metabolism and also maybe to the lack of nutrients. These data are in accordance 
with the literature where it is hypothesized that MO regrowth must not occur after aPDT 
treatment (Jori et al., 2006). Moreover, Costa et al. (unpublished data) also verified that 
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T4-like bacteriophages viability recovery does not occurr after an efficient treatment with 
the efficient Tri-Py+-Me-PF (Costa et al., unpublished data). 
It was also observed in this study that after several generations of 
photoinactivated cells, V. fischeri and E. coli do not develop resistance against the 
porphyrin Tri-Py+-Me-PF. In fact, after ten generations, it was not observed any 
considerable reduction on the efficiency of photoinactivation of bacteria. If bacterial 
resistance occurs, it is supposed to increase the time of irradiation to reach 99.99% of 
photosensitized cells. In this study, it was only necessary 25 minutes to destroy 99.99% of 
V. fischeri and E. coli cells during the several treatments of photoinactivated generations. 
This information is in agreement with the literature where it has not been reported that 
bacterial resistance occurs after several processes of photodynamic inactivation (Lauro et 
al., 2002; Jori and Coppellotti, 2007; Pedigo et al., 2009). 
Some authors affirm that stationary phase cultures demonstrate a certain level of 
resistance to the PS (Nitzan et al., 1989; Bhatti et al., 1998). Others refer that bacteria 
susceptibility to PS is independent from the growth phase (Gad et al., 2004a; Banfi et al., 
2006). In this study, the bacterial cultures were used at the same growth phase 
(stationary growth phase). As one bacterial colony has been aseptically removed from 
each TSA plate for each independent assay, the cellular density in each colony may have 
been different. To avoid differences in the PI due to differences of bacterial density, the 
bacterial growth of these bacteria was controlled in all the experiments.  
As shown by Alves et al. (2008), the use of a stable bioluminescent bacterial strain 
allows following the progress of the photoinactivation process with real-time results 
having into account that the bioluminescence signal reflects the viable bacterial 
abundance. The application of this method is considered also a simpler, faster, cost-
effective and sensitive way to evaluate which mechanism is responsible for the bacterial 
inactivation during the photodynamic process, to determine if bacteria recover from 
photoinactivation and to monitor the possible development of resistance to the ROS 
produced during the photochemical process. The relationship between viable counts and 
the bioluminescence signal of E. coli is similar in the absence and in the presence of Tri-
Py+-Me-PF demonstrating that the PS is not toxic to the recombinant bioluminescent E. 
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coli and it does not affect the relationship between bacterial growth and 
bioluminescence. The same result was obtained with the bioluminescent marine 
bacterium V. fischeri where the relationship between viable counts and the 
bioluminescence signal was similar in the presence and in the absence of the PS.  
In conclusion, the results show that singlet oxygen-mediated reaction (type II 
mechanism) plays the most important role on the photoinactivation process of the 
bioluminescent Escherichia coli by the cationic porphyrins Tri-Py+-Me-PF, Tetra-Py+-Me 
and Tri-SPy+-Me-PF. The use of scavengers to evaluate which pathway is involved in the 
photodynamic process represents an adequate and simple approach. However, it is 
essential to have into consideration that the scavengers must be selected having into 
account the chemical structure of the PS. Finally, the aPDT represents an adequate 
method to inactivate microorganisms, since bacteria do not recovery their metabolic 
activity after photoinactivation and bacterial resistance is not developed after several 
treatments of aPDT using the efficient meso-substituted Tri-Py+-Me-PF porphyrin. 
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